,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,BioPlanet_2019,Interferon signaling,49 of 168,4.640129581542801e-47,3.206329540846075e-44,0,0,27.94281045751634,2981.127831352483,IFITM3;CIITA;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;TRIM25;JAK2;B2M;DDX58;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;KPNB1;IRF9;SP100;IFI6;USP18;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;GBP3;STAT1;STAT2;MX1;EIF2AK2;ISG15;PML;PSMB8;ISG20;HLA-DRA;XAF1
1,BioPlanet_2019,Immune system,90 of 998,5.79403689650246e-41,2.0018397477415999e-38,0,0,7.526217696053077,697.2977440948493,IFITM3;CD40;CIITA;YWHAB;RNF19B;UBE2L6;ADAR;IFI35;IFIT1;IFI30;IFIT3;CTSS;IFIT2;ICAM1;HERC5;IFIH1;MT2A;CTSO;CDH1;DHX58;TRIM25;FBXO6;JAK2;B2M;TRIM21;PDIA3;DTX3L;RIPK2;DDX58;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;HLA-E;RBX1;TAPBP;PSMA3;PSMA4;IFI27;OAS1;PSMA2;IRF1;OAS3;IRF2;PSME1;TAX1BP1;IRF7;PSME2;TXNIP;RBCK1;TLR3;IRF9;KPNB1;CD274;SP100;UBA6;UNC93B1;IFI6;NLRC5;USP18;PSMB10;C2;SOCS1;PSMB2;UBB;PSMB3;UBC;TNFRSF14;GBP2;GBP1;GBP4;GBP3;CD74;ERAP2;STAT1;STAT2;MX1;STAT3;EIF2AK2;ISG15;PML;PSMB8;PSMB9;ISG20;CYLD;HLA-DRA;XAF1;LGMN
2,BioPlanet_2019,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",53 of 280,3.5568153420022103e-40,8.192531337745093e-38,0,0,15.978594031147235,1451.4082089796132,IFITM3;CIITA;YWHAB;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;TRIM25;JAK2;B2M;RIPK2;DDX58;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;RBX1;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;KPNB1;IRF9;SP100;IFI6;USP18;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;GBP3;STAT1;STAT2;STAT3;MX1;EIF2AK2;ISG15;PSMB8;PML;ISG20;HLA-DRA;XAF1
3,BioPlanet_2019,Interferon alpha/beta signaling,29 of 64,9.005878801065111e-35,1.555765562883998e-32,0,0,52.8025974025974,4139.332933607241,IFITM3;IFI6;ADAR;IFI35;IFIT1;USP18;IFIT3;IFIT2;SOCS1;GBP2;STAT1;STAT2;MX1;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PSMB8;HLA-E;ISG20;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;XAF1;IRF9
4,BioPlanet_2019,Interferon-gamma signaling pathway,28 of 97,4.6292101770294265e-27,6.397568464654667e-25,0,0,25.73200131325923,1560.3219457994655,CIITA;SP100;IFI30;ICAM1;MT2A;SOCS1;JAK2;GBP2;B2M;GBP1;GBP4;GBP3;STAT1;STAT3;HLA-B;HLA-C;HLA-A;HLA-F;PML;HLA-E;OAS1;IRF1;OAS3;IRF2;IRF7;HLA-DRA;CALM3;IRF9
5,BioPlanet_2019,Type II interferon signaling (interferon-gamma),20 of 50,5.764246965754599e-23,6.638491088894047e-21,0,0,41.289169295478445,2114.3268056532643,CIITA;CXCL9;STAT1;STAT2;HLA-B;IFI6;TAP1;EIF2AK2;ISG15;ICAM1;IFIT2;PSMB9;CXCL10;SOCS1;OAS1;IRF1;IRF2;JAK2;GBP1;IRF9
6,BioPlanet_2019,Antigen processing: cross presentation,23 of 79,1.5890884177716625e-22,1.5686572809717412e-20,0,0,25.64609872611465,1287.2728809747125,PDIA3;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;CTSS;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M
7,BioPlanet_2019,"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",33 of 255,7.612863012268085e-20,6.5756104268465595e-18,0,0,9.506178876244666,418.4796997862961,UBA6;RNF19B;UBE2L6;CTSS;PSMB10;SOCS1;PSMB2;UBB;PSMB3;UBC;FBXO6;B2M;TRIM21;PDIA3;DTX3L;ERAP2;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;HLA-E;PSMB9;RBX1;TAPBP;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1
8,BioPlanet_2019,Antigen processing and presentation,21 of 81,1.677196605987576e-19,1.2877142830415722e-17,0,0,21.7121835443038,938.6609681786974,PDIA3;CD74;CIITA;HLA-B;TAP2;HLA-C;TAP1;HLA-A;IFI30;HLA-F;CTSS;PSMB8;HLA-E;TAPBP;PSMB9;RFX5;PSME1;PSME2;HLA-DRA;B2M;LGMN
9,BioPlanet_2019,Adaptive immune system,45 of 606,5.4188045276054817e-17,3.744393928575388e-15,0,0,5.247417771591825,196.5371596552912,CD274;CD40;YWHAB;UBA6;RNF19B;UBE2L6;IFI30;PSMB10;CTSS;ICAM1;CTSO;SOCS1;PSMB2;UBB;PSMB3;CDH1;UBC;TNFRSF14;FBXO6;B2M;TRIM21;PDIA3;CD74;DTX3L;ERAP2;RIPK2;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;PSMB9;HLA-E;RBX1;TAPBP;PSMA3;PSMA4;PSMA2;PSME1;PSME2;HLA-DRA;RBCK1;LGMN
10,BioPlanet_2019,Interleukin-2 signaling pathway,53 of 847,1.121939642074692e-16,7.047820842487384e-15,0,0,4.434921240288076,162.87825893335034,IFITM3;BTG1;CSF1;YWHAB;IFIT1;CTSS;ICAM1;MT2A;CTSO;CASP3;NAMPT;TNFSF10;JAK2;TRIM21;PDIA3;WARS;BTN3A1;TAP1;TRAFD1;BTN3A3;BTN3A2;ATP1B1;KARS;TMX1;IRF1;TOP1;VAMP5;IRF9;MT1E;LY6E;MACF1;SP100;USP15;ABCB1;CREM;SAMHD1;SOCS1;UBC;TNFRSF14;GBP1;ZNF267;APOBEC3G;STAT1;MX1;STAT3;IFI44;NMI;CFLAR;GADD45G;THEMIS2;BCL6;FAS;CD68
11,BioPlanet_2019,Proteasome degradation,17 of 63,2.3869594814010314e-16,1.3744908347067608e-14,0,0,22.655502717391304,814.9488163878813,HLA-B;HLA-C;HLA-A;HLA-F;PSMB10;PSMB8;HLA-E;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
12,BioPlanet_2019,Thymic stromal lymphopoietin (TSLP) pathway,19 of 90,5.910479704487364e-16,3.1416472890775144e-14,0,0,16.487199929134555,578.1176393035316,CD274;CD40;CXCL9;CSF1;SLC44A1;PSMB10;PSMB8;ICAM1;PSMB9;CXCL10;PSMA4;PSMB2;PSMA2;LAMP3;IRF1;IRF2;PSME1;PSME2;IDO1
13,BioPlanet_2019,Apoptosis,26 of 242,6.550237260978051e-14,3.233009962382737e-12,0,0,7.526825056567822,228.489495151329,YWHAB;PSMB10;CASP7;PSMB2;UBB;PSMB3;CDH1;CASP3;UBC;TNFSF10;MCL1;CFLAR;PSMB8;PSMB9;PSMA3;H1F0;PSMA4;PSMA2;IRF1;IRF2;PSME1;NMT1;IRF7;PSME2;FAS;KPNB1
14,BioPlanet_2019,RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways,15 of 76,2.061672004619879e-12,9.497435701282242e-11,0,0,14.96945321250382,402.7906193432388,DDX58;NLRC5;UBE2L6;ISG15;HERC5;IFIH1;CYLD;UBB;IRF1;DHX58;IRF2;UBC;IRF7;TAX1BP1;TRIM25
15,BioPlanet_2019,Negative regulators of RIG-I/MDA5 signaling,11 of 33,3.672500451954972e-12,1.5860611326880535e-10,0,0,30.124233128834355,793.1755276278474,HERC5;IFIH1;CYLD;UBB;DDX58;UBC;NLRC5;TAX1BP1;TRIM25;UBE2L6;ISG15
16,BioPlanet_2019,Destabilization of mRNA by AUF1 (hnRNP D0),14 of 66,3.991595154549316e-12,1.6224660304668103e-10,0,0,16.346391998094784,429.0409747776112,APOBEC3G;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
17,BioPlanet_2019,HIV factor interactions with host,18 of 128,5.3960311662873166e-12,2.0714764088358532e-10,0,0,10.030037047591907,260.232895952933,APOBEC3G;HLA-A;RANGAP1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M;KPNB1
18,BioPlanet_2019,Endosomal/vacuolar pathway,7 of 9,1.2675168803953676e-11,4.6097587597536803e-10,0,0,208.5257575757576,5232.198240873077,HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
19,BioPlanet_2019,Apoptosis regulation,14 of 78,4.3999343376267056e-11,1.5201773136500271e-09,0,0,13.273316563467493,316.5267413791057,POMP;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;CASP3;UBC;PSME1;PSME2
20,BioPlanet_2019,T cell receptor regulation of apoptosis,36 of 603,5.1340467630825466e-11,1.6893458634714472e-09,0,0,4.028054632705795,95.4348528870382,IFITM3;CXCL9;BTG1;ABCB1;CEBPD;MAX;C2;SH3BGRL;CASP3;NAMPT;GBP1;GBP3;MCL1;EIF5A;STAT1;MX1;HLA-B;SHISA5;TAP1;CFLAR;PSMB8;PSMB9;CXCL10;PPA1;NCL;IRF1;PSME1;S100A6;IRF7;PSME2;NUCB1;FAS;LAP3;PTMA;ATF3;TLR3
21,BioPlanet_2019,Antiviral mechanism by interferon-stimulated genes,13 of 70,1.4024536255171055e-10,4.40497934196509e-09,0,0,13.801061295213342,313.11333967028565,DDX58;STAT1;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;HERC5;UBB;UBC;TRIM25;KPNB1
22,BioPlanet_2019,mRNA stability regulation by proteins that bind AU-rich elements,14 of 86,1.727660010196183e-10,5.1904915958502715e-09,0,0,11.793687650498796,265.1112839522877,YWHAB;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;XRN1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
23,BioPlanet_2019,Cyclin A-Cdk2-associated events at S phase entry,13 of 72,2.0326215472958374e-10,5.8522562049226e-09,0,0,13.331868591755596,297.5209729575438,MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
24,BioPlanet_2019,Degradation of beta-catenin by the destruction complex,13 of 73,2.435886626167329e-10,6.732790634726497e-09,0,0,13.10900205761317,290.1748410077492,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
25,BioPlanet_2019,Ubiquitin-mediated degradation of phosphorylated Cdc25A,12 of 64,6.45393173059072e-10,1.7152564714762262e-08,0,0,13.924970414201184,294.6685466230276,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
26,BioPlanet_2019,Activation of NF-kappaB in B cells,12 of 68,1.3472568578971142e-09,3.3869876134591185e-08,0,0,12.927692307692308,264.05063976003146,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
27,BioPlanet_2019,HIV infection,19 of 200,1.3724407116766326e-09,3.3869876134591185e-08,0,0,6.431043469196289,131.23621489224638,APOBEC3G;HLA-A;RANGAP1;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;NMT1;PSME2;B2M;KPNB1
28,BioPlanet_2019,APC/C-mediated degradation of cell cycle proteins,12 of 82,1.2412064538006198e-08,2.957495377849063e-07,0,0,10.334769230769233,188.1403078048508,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
29,BioPlanet_2019,Innate immune system,22 of 319,2.705865287779212e-08,6.232509712851452e-07,0,0,4.554027042915932,79.35510070775207,RIPK2;DDX58;UNC93B1;NLRC5;UBE2L6;ISG15;CTSS;C2;HERC5;IFIH1;CYLD;UBB;IRF1;DHX58;UBC;IRF2;TAX1BP1;IRF7;TRIM25;TXNIP;TLR3;LGMN
30,BioPlanet_2019,DNA replication pre-Initiation,12 of 88,2.810917374979795e-08,6.265625503583995e-07,0,0,9.515951417004048,165.45546353298622,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
31,BioPlanet_2019,Autodegradation of Cdh1 by Cdh1-APC/C,10 of 58,4.1130375212534194e-08,8.881590397456601e-07,0,0,12.496814475025484,212.52731196103437,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
32,BioPlanet_2019,S phase,13 of 112,5.319885292139145e-08,1.1139517384448936e-06,0,0,7.929043521636114,132.80536571434922,MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
33,BioPlanet_2019,Licensing factor removal from origins,10 of 61,6.797141173304234e-08,1.363662534570497e-06,0,0,11.759908856508964,194.0876365092597,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
34,BioPlanet_2019,Mitotic G1-G1/S phases,14 of 135,6.907118481905557e-08,1.363662534570497e-06,0,0,7.000179106005168,115.41985052350606,MAX;PPP2R2A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
35,BioPlanet_2019,Downstream signaling events Of B cell receptor (BCR),12 of 98,9.564163300838773e-08,1.835788011355442e-06,0,0,8.40515205724508,135.84959494502627,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
36,BioPlanet_2019,Allograft rejection,8 of 37,1.5082130077015568e-07,2.8166896981669614e-06,0,0,16.462844565559166,258.58470057230545,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
37,BioPlanet_2019,Cell cycle checkpoints,12 of 117,6.780282063705194e-07,1.2329407647421812e-05,0,0,6.877538461538461,97.68908551746112,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
38,BioPlanet_2019,Interleukin-12-mediated signaling events,9 of 65,1.3720590543640233e-06,2.431007196321898e-05,0,0,9.607088414634148,129.6879885882167,SOCS1;RIPK2;STAT1;STAT3;HLA-DRA;HLA-A;JAK2;B2M;GADD45G
39,BioPlanet_2019,HIF-1 degradation in normoxia,10 of 88,2.2756808776367096e-06,3.931238716117416e-05,0,0,7.678585430879009,99.76963627968756,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
40,BioPlanet_2019,Autoimmune thyroid disease,8 of 52,2.3596780289444303e-06,3.976920775611223e-05,0,0,10.842221608179054,140.48250682754576,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
41,BioPlanet_2019,Viral myocarditis,9 of 71,2.925396734568964e-06,4.812974151397986e-05,0,0,8.674714791502753,110.53391376044893,CD40;CASP3;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ICAM1;HLA-E
42,BioPlanet_2019,Graft-versus-host disease,7 of 41,4.978529579354518e-06,8.00038125426505e-05,0,0,12.246256684491978,149.53139841278357,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
43,BioPlanet_2019,Type 1 diabetes mellitus,7 of 43,6.932681994258213e-06,0.00010887461950073694,0,0,11.56473063973064,137.38048613173643,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
44,BioPlanet_2019,TRAF6-mediated IRF7 activation,6 of 30,9.237875679711333e-06,0.0001418527132151229,0,0,14.83308157099698,171.94802747344656,IFIH1;DDX58;IRF1;IRF2;IRF7;TRIM25
45,BioPlanet_2019,Signaling by the B cell receptor (BCR),12 of 151,9.945041697758824e-06,0.00014939182202502928,0,0,5.1862313226342005,59.73727591944186,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
46,BioPlanet_2019,FSH regulation of apoptosis,16 of 263,1.0876066818873116e-05,0.00015990132280513454,0,0,3.9181202466987024,44.77998428029116,IFITM3;STAT1;CREM;RAB27A;MT1X;ISG15;IFI35;CFLAR;RANGAP1;RGS4;ID4;S100A6;ACP2;GBP1;ANGPTL1;PLA1A
47,BioPlanet_2019,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",11 of 135,1.8420865984783777e-05,0.00026518371657261645,0,0,5.316866218088264,57.964616486057096,CXCL10;CD40;CSF1;RIPK2;IRF1;IFIT5;TNFSF10;TAPBPL;CFLAR;OPTN;ICAM1
48,BioPlanet_2019,RIG-I-like receptor signaling pathway,8 of 71,2.5272252588243657e-05,0.00035639033751992585,0,0,7.5650118203309695,80.08172860314302,IFIH1;CXCL10;CYLD;DDX58;DHX58;IRF7;TRIM25;ISG15
49,BioPlanet_2019,Cell cycle,21 of 453,3.1102873368980145e-05,0.0004282741805308684,0,0,2.9583553094233475,30.70243369644557,MAX;YWHAB;PPP2R2A;RANGAP1;PSMB10;PSMB8;REC8;SYNE2;PSMB9;GADD45G;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;CDH1;UBC;PSME1;PSME2
50,BioPlanet_2019,Disease,27 of 674,3.160923763686583e-05,0.0004282741805308684,0,0,2.559864386498479,26.525471308120697,YWHAB;PSMB10;PSMB2;UBB;PSMB3;UBC;B2M;APOBEC3G;STAT1;STAT3;RAB27A;EIF2AK2;HLA-A;RANGAP1;PDIA6;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMA2;PSME1;NMT1;PSME2;ATF3;ITM2B;KPNB1
51,BioPlanet_2019,Toll-like receptor endosomal trafficking and processing,4 of 12,3.5224182393313825e-05,0.0004680751929573048,0,0,29.51201201201201,302.6096109881204,UNC93B1;CTSS;TLR3;LGMN
52,BioPlanet_2019,Proteasome complex,5 of 24,4.306130741223094e-05,0.0005614219513556902,0,0,15.570703868103996,156.53050631563082,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3
53,BioPlanet_2019,CTL mediated immune response against target cells,4 of 13,5.020455109935013e-05,0.0006424323112898321,0,0,26.231564898231564,259.6768814593538,FAS;HLA-A;B2M;ICAM1
54,BioPlanet_2019,Interleukin-4 regulation of apoptosis,15 of 267,5.132950937377051e-05,0.0006448852904959168,0,0,3.588250517598344,35.44202854971793,NNMT;RSAD2;RIPK2;STAT1;DENND4A;MX1;IFI6;CREM;RNF19B;UBE2L6;BCL6;CASP3;TNFSF10;GBP2;FKBP5
55,BioPlanet_2019,DNA replication,13 of 207,5.241206713618847e-05,0.0006467274712697541,0,0,4.026616393025328,39.68783593348243,RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
56,BioPlanet_2019,TRAF3-dependent IRF activation pathway,4 of 14,6.93546226413705e-05,0.0008407727060559125,0,0,23.607207207207207,226.0691732770376,IFIH1;DDX58;IRF7;TRIM25
57,BioPlanet_2019,Cell adhesion molecules (CAMs),10 of 133,8.725765887462018e-05,0.0010395696945234,0,0,4.858158673329853,45.40748554177058,CD274;CD40;CDH1;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ICAM1;HLA-E
58,BioPlanet_2019,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,4 of 15,9.332140797492112e-05,0.001092967676452,0,0,21.46000546000546,199.13728422643885,UBB;UBC;IRF7;TLR3
59,BioPlanet_2019,Amino acid metabolism,12 of 195,0.00012276583412855602,0.0014138531897138,0,0,3.930390920554855,35.3940813225725,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;GLUL;PSMB8;PSMB10;IDO1;PSMB9
60,BioPlanet_2019,Toll-like receptor signaling pathway regulation,10 of 142,0.00015035918878250333,0.0017032491712903,0,0,4.524835511074043,39.829790082328856,CXCL10;CYLD;CD40;CXCL9;SOCS1;STAT1;IRF7;TRAFD1;RBCK1;TLR3
61,BioPlanet_2019,Immunoregulatory interactions between a lymphoid and a non-lymphoid cell,9 of 119,0.00018745818035646267,0.0020892516552631,0,0,4.877411308203991,41.85772326866219,CD40;CDH1;HLA-B;HLA-C;HLA-A;HLA-F;B2M;ICAM1;HLA-E
62,BioPlanet_2019,Lysosome,9 of 121,0.00021261473924622564,0.0023320124574466,0,0,4.789824695121951,40.502895405694055,LAPTM4A;CTSO;LAMP3;ACP2;AP3B1;CD68;GNS;CTSS;LGMN
63,BioPlanet_2019,Bystander B cell activation,3 of 8,0.0002493638217434992,0.0026923500128868,0,0,35.31377245508982,292.9841596711931,CD40;FAS;HLA-DRA
64,BioPlanet_2019,Oncostatin M,15 of 311,0.0002759285588602998,0.0029333328334225,0,0,3.047937300654692,24.978969558525037,CEBPD;STAT1;STAT3;SECTM1;ICAM1;BTC;MT2A;H1F0;SOCS1;OAS1;IRF1;NAMPT;B2M;ATF3;MT1E
65,BioPlanet_2019,Primary immunodeficiency,5 of 35,0.0002825476476950696,0.002958188250868,0,0,9.855923694779117,80.53929050791373,CD40;CIITA;RFX5;TAP2;TAP1
66,BioPlanet_2019,"cAMP receptor, G-protein-independent pathways inferred from amoeba model",3 of 9,0.0003693801898193211,0.0038095777785843,0,0,29.426646706586823,232.5789202688228,STAT1;STAT2;STAT3
67,BioPlanet_2019,Toll receptor cascades,10 of 159,0.0003754717556720153,0.0038154556348435,0,0,4.005089998563307,31.589455714689525,UBB;RIPK2;UNC93B1;UBC;IRF7;EIF2AK2;UBE2L6;CTSS;TLR3;LGMN
68,BioPlanet_2019,FAS pathway and stress induction of heat shock protein regulation,5 of 39,0.00047427026333089566,0.0047495761153862,0,0,8.69463146704465,66.54638972066162,CASP7;RIPK2;CASP3;FAS;CFLAR
69,BioPlanet_2019,Interferon-alpha signaling pathway,3 of 10,0.0005211092167563334,0.0051440924111232,0,0,25.221556886227543,190.6636432879255,STAT1;STAT2;IRF9
70,BioPlanet_2019,TGF-beta regulation of extracellular matrix,21 of 565,0.0006433714453666432,0.0062615446302584,0,0,2.3356001023827253,17.16383076422536,CSF1;CEBPD;GOLM1;DENND4A;INPP1;CREM;TAP1;LMO7;BTN3A2;IFIT1;ATP1B1;SAT1;IFIT3;RGS4;PPA1;TNFSF10;ID4;GBP2;ATF3;IRF9;IDO1
71,BioPlanet_2019,Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),5 of 42,0.0006724141416509842,0.0064533079427893,0,0,7.988440247476392,58.35264921448984,CSF1;STAT1;STAT3;EIF2AK2;KPNB1
72,BioPlanet_2019,B lymphocyte cell surface molecules,3 of 11,0.0007076019338344733,0.0066979854284879,0,0,22.067739520958085,160.0711923245111,CD40;HLA-DRA;ICAM1
73,BioPlanet_2019,Interferon alpha signaling regulation,4 of 25,0.0007571521775921972,0.0070701642529217,0,0,11.235235235235235,80.73579704049152,SOCS1;STAT1;STAT2;USP18
74,BioPlanet_2019,Interleukin-27-mediated signaling events,4 of 26,0.0008830306164159009,0.0081356554125785,0,0,10.723996723996724,75.41276090627198,STAT1;STAT2;STAT3;JAK2
75,BioPlanet_2019,Assembly of HIV virion,3 of 12,0.000931729228614326,0.0083613622983441,0,0,19.61477045908184,136.88105411013083,UBB;UBC;NMT1
76,BioPlanet_2019,NF-kappaB activation through FADD/RIP-1 pathway,3 of 12,0.000931729228614326,0.0083613622983441,0,0,19.61477045908184,136.88105411013083,IFIH1;DDX58;TRIM25
77,BioPlanet_2019,Signaling by ERBB4,7 of 93,0.000993997863481016,0.0088058015854536,0,0,4.828717406624383,33.38466810584637,PSENEN;BTC;UBB;YWHAB;UBC;JAK2;RBX1
78,BioPlanet_2019,Activation of DNA fragmentation factor,3 of 13,0.0011961881516228,0.01020451867619,0,0,17.65239520958084,118.7761768139254,H1F0;CASP3;KPNB1
79,BioPlanet_2019,Death receptor signaling,3 of 13,0.0011961881516228,0.01020451867619,0,0,17.65239520958084,118.7761768139254,TNFSF10;FAS;CFLAR
80,BioPlanet_2019,Interleukin-22 soluble receptor signaling pathway,3 of 13,0.0011961881516228,0.01020451867619,0,0,17.65239520958084,118.7761768139254,STAT1;STAT3;JAK2
81,BioPlanet_2019,Phagosome,9 of 154,0.0012290135814043,0.010356687618907,0,0,3.6934819175777966,24.75202935920432,HLA-B;TAP2;HLA-C;TAP1;HLA-DRA;HLA-A;HLA-F;CTSS;HLA-E
82,BioPlanet_2019,Interleukin-6 signaling pathway,6 of 71,0.001249153439375,0.0103995786338333,0,0,5.4653962351847545,36.53775445543069,CEBPD;STAT1;IRF1;STAT3;JAK2;MCL1
83,BioPlanet_2019,Interferon gamma signaling regulation,3 of 14,0.0015035080450505,0.0123681435610708,0,0,16.046815459989112,104.30356562069318,SOCS1;STAT1;JAK2
84,BioPlanet_2019,Apoptosis intrinsic pathway,4 of 30,0.0015351988333824,0.0124802634572622,0,0,9.072303072303072,58.78031685987706,CASP7;YWHAB;CASP3;NMT1
85,BioPlanet_2019,Prolactin activation of MAPK signaling,6 of 75,0.0016604926923086,0.0133418657021547,0,0,5.147510836726652,32.947368487685495,SOCS1;STAT1;CASP3;IRF1;STAT3;JAK2
86,BioPlanet_2019,Apoptotic execution  phase,5 of 52,0.0017911699504909,0.014226418802175,0,0,6.285567803127403,39.75550149092608,CASP7;H1F0;CDH1;CASP3;KPNB1
87,BioPlanet_2019,TRAF6-mediated induction of TAK1 complex,3 of 15,0.0018560564968986,0.014574261810875,0,0,14.708832335329342,92.5082769298772,UBB;UBC;TLR3
88,BioPlanet_2019,Interleukin-4 signaling pathway,7 of 104,0.0019054288322196,0.0147938350906038,0,0,4.278725398313028,26.79786334840393,SOCS1;BCL6;STAT1;STAT3;HLA-DRA;PARP14;JAK2
89,BioPlanet_2019,Cell death signaling by NRIF in the nucleus,3 of 16,0.0022560451245084,0.0171254230348216,0,0,13.576692768309536,82.73829285401925,PSENEN;UBB;UBC
90,BioPlanet_2019,p75 neurotrophin receptor signaling via NF-kB,3 of 16,0.0022560451245084,0.0171254230348216,0,0,13.576692768309536,82.73829285401925,UBB;RIPK2;UBC
91,BioPlanet_2019,Natural killer cell-mediated cytotoxicity,8 of 137,0.0022800852665753,0.0171254230348216,0,0,3.6820998562710585,22.400210740607932,CASP3;TNFSF10;HLA-B;HLA-C;FAS;HLA-A;ICAM1;HLA-E
92,BioPlanet_2019,Apoptosis modulation and signaling,6 of 80,0.0023105559594476,0.0171676792255736,0,0,4.79848126071691,29.128062966821943,CASP7;CASP3;TNFSF10;FAS;CFLAR;MCL1
93,BioPlanet_2019,EPO receptor signaling,4 of 34,0.0024642292215107,0.0179240251796199,0,0,7.861061061061061,47.21255960748123,SOCS1;STAT1;STAT3;JAK2
94,BioPlanet_2019,Induction of apoptosis through DR3 and DR4/5 death receptors,4 of 34,0.0024642292215107,0.0179240251796199,0,0,7.861061061061061,47.21255960748123,CASP7;CASP3;TNFSF10;CFLAR
95,BioPlanet_2019,Leptin influence on immune response,7 of 110,0.0026207915901373,0.0188642394665091,0,0,4.028243601059135,23.94500333388742,IRF2;TNFSF10;CTSS;ANGPTL1;CXCL16;IFIT2;C2
96,BioPlanet_2019,Caspase cascade in apoptosis,5 of 59,0.0031356959743693,0.0223377929720538,0,0,5.468819723337796,31.52722139913545,CASP7;CASP3;TNFSF10;FAS;TOP1
97,BioPlanet_2019,Transcriptional activity regulation by PML,3 of 18,0.003206443081092,0.0226086956023941,0,0,11.765269461077844,67.56315441072502,SP100;FAS;PML
98,BioPlanet_2019,Fas signaling pathway,7 of 115,0.0033610841774269,0.0233093746281163,0,0,3.8407687991021326,21.87506676006609,CASP7;RIPK2;CASP3;FAS;CD47;CFLAR;C2
99,BioPlanet_2019,Interleukin-23-mediated signaling events,4 of 37,0.0033732814223033,0.0233093746281163,0,0,7.145327145327145,40.67026816374424,CXCL9;STAT1;STAT3;JAK2
100,BioPlanet_2019,Apoptosis modulation by HSP70,3 of 19,0.0037605455602886,0.0257280889322717,0,0,11.02937874251497,61.57913073686957,CASP7;CASP3;FAS
101,BioPlanet_2019,Circadian rhythm,5 of 62,0.0038906513513863,0.0263572557236077,0,0,5.180194462058761,28.745824733691247,HELZ2;UBB;NAMPT;UBC;RBX1
102,BioPlanet_2019,Interleukin-1 regulation of extracellular matrix,7 of 120,0.0042510680047057,0.0285193008859387,0,0,3.6698846875838025,20.03971739561839,RGS4;MT2A;SLC25A28;NAMPT;ALDH1A1;HLA-B;ICAM1
103,BioPlanet_2019,Integrated breast cancer pathway,8 of 152,0.0043087204389168,0.0286281329162649,0,0,3.296014859844647,17.953769678928214,USP15;APOBEC3G;CDH1;MAX;STAT1;CASP3;MYCBP2;PML
104,BioPlanet_2019,Apoptotic signaling in response to DNA damage,3 of 20,0.0043694849633352,0.028755372472997,0,0,10.380063402606552,56.39602766613993,CASP7;STAT1;CASP3
105,BioPlanet_2019,Nuclear signaling by ErbB4,4 of 40,0.0044871080995636,0.0292508650641368,0,0,6.548882215548883,35.40683858261972,PSENEN;BTC;JAK2;RBX1
106,BioPlanet_2019,Bioactive peptide-induced signaling pathway,4 of 41,0.0049072767552529,0.031690918111026,0,0,6.371560749939128,33.877818669688665,STAT1;STAT3;CALM3;JAK2
107,BioPlanet_2019,Telomerase regulation,5 of 67,0.0054247102533871,0.034708099861949,0,0,4.761222308589195,24.8383006909515,ZNFX1;MAX;IRF1;NCL;NBN
108,BioPlanet_2019,Apoptotic factor-mediated response,2 of 7,0.0056211463820458,0.0356349738531533,0,0,23.47223880597015,121.6148250086244,CASP7;CASP3
109,BioPlanet_2019,TRAF6 mediated NF-kB activation,3 of 22,0.0057578014630867,0.0361694619181176,0,0,9.286479672234478,47.89222894992312,IFIH1;DDX58;TRIM25
110,BioPlanet_2019,Growth hormone receptor signaling,4 of 43,0.0058251102902341,0.0362626235184847,0,0,6.044198044198044,31.100888529535556,SOCS1;STAT1;STAT3;JAK2
111,BioPlanet_2019,MicroRNA regulation of DNA damage response,5 of 70,0.0065268434522219,0.0402682930846908,0,0,4.540778498609824,22.8484338470438,CASP3;FAS;NBN;PML;GADD45G
112,BioPlanet_2019,Interleukin-12/STAT4 pathway,4 of 45,0.0068506746544089,0.041892178638908,0,0,5.74877316340731,28.648482988247807,IRF1;STAT3;HLA-DRA;JAK2
113,BioPlanet_2019,TNF-alpha signaling pathway,6 of 101,0.0072724125539245,0.0430379662439589,0,0,3.733757354110352,18.383778586867617,CYLD;CASP7;STAT1;CASP3;CFLAR;GLUL
114,BioPlanet_2019,Cytosolic tRNA aminoacylation,3 of 24,0.0073820285528125,0.0430379662439589,0,0,8.401197604790418,41.23901586526217,WARS;KARS;PPA1
115,BioPlanet_2019,Nicotinate and nicotinamide metabolism,3 of 24,0.0073820285528125,0.0430379662439589,0,0,8.401197604790418,41.23901586526217,NT5C3A;NNMT;NAMPT
116,BioPlanet_2019,Adipogenesis,7 of 133,0.0073963378541901,0.0430379662439589,0,0,3.289057239057239,16.138648329022164,SOCS1;CEBPD;STAT1;STAT2;NAMPT;STAT3;FAS
117,BioPlanet_2019,Membrane trafficking,7 of 133,0.0073963378541901,0.0430379662439589,0,0,3.289057239057239,16.138648329022164,GJD2;VAMP8;UBB;UBC;AP3B1;GNS;CHMP5
118,BioPlanet_2019,Downregulation of ERBB4 signaling,2 of 8,0.0074117481664704,0.0430379662439589,0,0,19.559203980099504,95.93181158499544,UBB;UBC
119,BioPlanet_2019,MHC class II antigen presentation,6 of 103,0.0079802861988831,0.0459531480285689,0,0,3.6563989161242096,17.66326242574943,CD74;CTSO;HLA-DRA;IFI30;CTSS;LGMN
120,BioPlanet_2019,Cellular response to hypoxia,3 of 25,0.0082854236154993,0.0469280960517214,0,0,8.018916712030485,38.436732663751606,UBB;UBC;RBX1
121,BioPlanet_2019,TPO signaling pathway,3 of 25,0.0082854236154993,0.0469280960517214,0,0,8.018916712030485,38.436732663751606,STAT1;STAT3;JAK2
122,BioPlanet_2019,Diurnally regulated genes with circadian orthologs,4 of 48,0.0086019650182556,0.0483248603871108,0,0,5.355992355992356,25.47183890517072,DNAJA1;BTG1;PSMA4;ETV6
691,Panther_2016,JAK/STAT signaling pathway Homo sapiens P00038,4 of 14,6.93546226413705e-05,0.0035370857547098,0,0,23.607207207207207,226.0691732770376,SOCS1;STAT1;STAT3;JAK2
692,Panther_2016,FAS signaling pathway Homo sapiens P00020,5 of 31,0.00015626929108657547,0.0039848669227076,0,0,11.374536607970343,99.68564049919183,CASP7;PARP3;CASP3;FAS;CFLAR
693,Panther_2016,Apoptosis signaling pathway Homo sapiens P00006,8 of 102,0.0003318092138964222,0.0055222938105671,0,0,5.062148354135679,40.5526194389407,CASP7;CASP3;TNFSF10;EIF2AK2;FAS;CFLAR;ATF3;MCL1
694,Panther_2016,Parkinson disease Homo sapiens P00049,7 of 81,0.0004331210831817336,0.0055222938105671,0,0,5.615192465192465,43.48682003868089,PSMA3;PSMA4;YWHAB;PSMA2;PSMB3;UBE2L6;PSMB10
742,KEGG_2019_Human,Epstein-Barr virus infection,28 of 201,7.355998116441713e-18,1.5153356119869926e-15,0,0,10.208578857773537,402.7388040087766,CD40;ICAM1;CASP3;CIR1;B2M;PDIA3;STAT1;DDX58;STAT2;STAT3;HLA-B;TAP2;HLA-C;EIF2AK2;TAP1;ISG15;HLA-A;HLA-F;HLA-E;GADD45G;TAPBP;CXCL10;OAS1;OAS3;IRF7;FAS;HLA-DRA;IRF9
743,KEGG_2019_Human,Antigen processing and presentation,19 of 77,2.5474219284356337e-17,2.623844586288703e-15,0,0,20.195998698763827,771.666182602573,PDIA3;CD74;CIITA;TAP2;HLA-B;TAP1;HLA-C;HLA-A;IFI30;HLA-F;CTSS;TAPBP;HLA-E;RFX5;PSME1;PSME2;HLA-DRA;B2M;LGMN
744,KEGG_2019_Human,Influenza A,22 of 171,1.456757482914689e-13,1.0003068049347532e-11,0,0,9.146862682433152,270.35741634961795,CIITA;RSAD2;DDX58;STAT1;STAT2;MX1;EIF2AK2;ADAR;PML;ICAM1;IFIH1;CXCL10;OAS1;OAS3;TNFSF10;IRF7;TRIM25;HLA-DRA;FAS;JAK2;IRF9;TLR3
745,KEGG_2019_Human,Hepatitis C,19 of 155,1.644511274905332e-11,8.469233065762461e-10,0,0,8.578731964483907,213.0184314732105,RSAD2;YWHAB;DDX58;STAT1;STAT2;MX1;STAT3;EIF2AK2;PPP2R2A;CFLAR;IFIT1;CXCL10;OAS1;CASP3;OAS3;IRF7;FAS;IRF9;TLR3
746,KEGG_2019_Human,Proteasome,11 of 45,1.6082935450088994e-10,6.626169405436666e-09,0,0,19.48024178996752,439.2926448311287,PSMA3;PSMA4;PSMB2;PSMB3;PSMA2;POMP;PSME1;PSME2;PSMB10;PSMB8;PSMB9
747,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,19 of 186,3.994568659330939e-10,1.3714685730369555e-08,0,0,6.975181712047603,150.94931681863838,GABARAPL1;STAT1;STAT2;STAT3;HLA-B;HLA-C;EIF2AK2;HLA-A;HLA-F;ICAM1;HLA-E;UBB;CASP3;IRF7;FAS;CALM3;JAK2;IRF9;TLR3
748,KEGG_2019_Human,Herpes simplex virus 1 infection,30 of 492,1.395003714412339e-09,4.1052966452705976e-08,0,0,4.061297009179746,82.81134365706157,SP100;IFIH1;CASP3;TNFRSF14;JAK2;B2M;ZNF267;PDIA3;CD74;STAT1;DDX58;STAT2;HLA-B;TAP2;HLA-C;TAP1;EIF2AK2;HLA-A;HLA-F;PML;HLA-E;TAPBP;BST2;OAS1;OAS3;IRF7;FAS;HLA-DRA;TLR3;IRF9
749,KEGG_2019_Human,Necroptosis,16 of 162,1.603470660017064e-08,4.12893694954394e-07,0,0,6.66308197840652,119.5923955287175,PARP3;MLKL;STAT1;STAT2;STAT3;EIF2AK2;CFLAR;CYLD;TNFSF10;FAS;RBCK1;JAK2;GLUL;IRF9;TLR3;CHMP5
750,KEGG_2019_Human,NOD-like receptor signaling pathway,16 of 178,6.091629803791261e-08,1.394306377312222e-06,0,0,6.000076920118457,99.6838684029628,GSDMD;GABARAPL1;RIPK2;STAT1;STAT2;OAS1;OAS3;NAMPT;IRF7;TXNIP;RBCK1;GBP2;GBP1;IRF9;GBP4;GBP3
751,KEGG_2019_Human,Measles,14 of 138,9.120562676814313e-08,1.878835911423748e-06,0,0,6.829771297313492,110.71161203696286,DDX58;STAT1;STAT2;MX1;STAT3;EIF2AK2;ADAR;IFIH1;OAS1;CASP3;OAS3;IRF7;FAS;IRF9
752,KEGG_2019_Human,Human immunodeficiency virus 1 infection,17 of 212,1.2518161465421446e-07,2.3443102380698343e-06,0,0,5.303782051282052,84.29566128837615,PDIA3;APOBEC3G;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;SAMHD1;HLA-E;RBX1;TAPBP;BST2;CASP3;FAS;CALM3;B2M
753,KEGG_2019_Human,Allograft rejection,8 of 38,1.882583293832462e-07,3.2317679877457267e-06,0,0,15.913272543059778,246.4241978367164,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
754,KEGG_2019_Human,Viral myocarditis,9 of 59,5.893628635902484e-07,9.33913460766086e-06,0,0,10.763231707317074,154.39020416022217,CD40;CASP3;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ICAM1;HLA-E
755,KEGG_2019_Human,Autoimmune thyroid disease,8 of 53,2.738798023857662e-06,4.029945663676274e-05,0,0,10.600742992232354,135.7742251972279,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
756,KEGG_2019_Human,Graft-versus-host disease,7 of 41,4.978529579354518e-06,6.837180622313537e-05,0,0,12.246256684491978,149.53139841278357,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
757,KEGG_2019_Human,Type I diabetes mellitus,7 of 43,6.932681994258213e-06,8.92582806760745e-05,0,0,11.56473063973064,137.38048613173643,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-E
758,KEGG_2019_Human,RIG-I-like receptor signaling pathway,8 of 70,2.2754281095289487e-05,0.0002757283473899785,0,0,7.687420335326993,82.18434468567959,IFIH1;CXCL10;CYLD;DDX58;DHX58;IRF7;TRIM25;ISG15
759,KEGG_2019_Human,Human cytomegalovirus infection,14 of 225,3.0079049110656413e-05,0.0003442380064886234,0,0,3.995832905374672,41.603340222846725,PDIA3;STAT3;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;HLA-E;TAPBP;CASP3;FAS;CALM3;B2M
760,KEGG_2019_Human,TNF signaling pathway,9 of 110,0.00010269886097763168,0.0010697316436475,0,0,5.31447717942526,48.8066147295619,CXCL10;CASP7;CSF1;MLKL;CASP3;IRF1;FAS;CFLAR;ICAM1
761,KEGG_2019_Human,Hepatitis B,11 of 163,0.00010385744113083166,0.0010697316436475,0,0,4.331227801097836,39.72814957305903,IFIH1;YWHAB;DDX58;STAT1;CASP3;STAT2;STAT3;IRF7;FAS;JAK2;TLR3
762,KEGG_2019_Human,Apoptosis,10 of 143,0.0001592925473419929,0.001468119316052,0,0,4.490584258812168,39.26911809328296,CTSO;CASP7;PARP3;CASP3;TNFSF10;FAS;CFLAR;CTSS;MCL1;GADD45G
763,KEGG_2019_Human,Viral carcinogenesis,12 of 201,0.00016317430083846103,0.001468119316052,0,0,3.804444444444445,33.177386702434326,SP100;YWHAB;CASP3;STAT3;HLA-B;IRF7;HLA-C;EIF2AK2;HLA-A;HLA-F;IRF9;HLA-E
764,KEGG_2019_Human,Human papillomavirus infection,16 of 330,0.00016391623431649273,0.001468119316052,0,0,3.071452665833284,26.77125759346,STAT1;STAT2;MX1;HLA-B;HLA-C;EIF2AK2;PPP2R2A;ISG15;HLA-A;HLA-F;HLA-E;CASP3;IRF1;FAS;TLR3;IRF9
765,KEGG_2019_Human,Cell adhesion molecules (CAMs),10 of 145,0.0001785056757861649,0.0015321737171645,0,0,4.423604032166724,38.17964051353353,CD274;CD40;CDH1;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;ICAM1;HLA-E
766,KEGG_2019_Human,Lysosome,9 of 123,0.00024051510826172368,0.0019818444920766,0,0,4.705311296534018,39.20807754331683,LAPTM4A;CTSO;LAMP3;ACP2;AP3B1;CD68;GNS;CTSS;LGMN
767,KEGG_2019_Human,Primary immunodeficiency,5 of 37,0.0003690817751874242,0.0029242632957157,0,0,9.23898719879518,73.02950340828981,CD40;CIITA;RFX5;TAP2;TAP1
768,KEGG_2019_Human,Toxoplasmosis,8 of 113,0.0006601818087504026,0.0050369426889845,0,0,4.529280648429585,33.16790086946305,CD40;CIITA;SOCS1;STAT1;CASP3;STAT3;HLA-DRA;JAK2
769,KEGG_2019_Human,Mitophagy,6 of 65,0.0007837435233109945,0.0057661130643594,0,0,6.0230426545138,43.07336028011604,GABARAPL1;USP15;UBB;CALCOCO2;TAX1BP1;OPTN
770,KEGG_2019_Human,Tuberculosis,10 of 179,0.0009451196180005044,0.0067136083209691,0,0,3.5274957928451225,24.566182879699404,CD74;CIITA;RIPK2;STAT1;CASP3;RFX5;HLA-DRA;CALM3;JAK2;CTSS
771,KEGG_2019_Human,Phagosome,9 of 152,0.0011213529679203,0.0076999570463863,0,0,3.745522769913014,25.4441576278057,TAP2;HLA-B;TAP1;HLA-C;HLA-DRA;HLA-A;HLA-F;CTSS;HLA-E
772,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,8 of 131,0.001720623065985,0.0114338177933199,0,0,3.8629006350853774,24.58762833339521,CASP3;TNFSF10;HLA-B;HLA-C;FAS;HLA-A;ICAM1;HLA-E
773,KEGG_2019_Human,Pertussis,6 of 76,0.0017777467599457,0.0114442447671506,0,0,5.073716012084592,32.12884281634427,CASP7;CASP3;IRF1;SERPING1;CALM3;C2
774,KEGG_2019_Human,African trypanosomiasis,4 of 37,0.0033732814223033,0.0210574537271059,0,0,7.145327145327145,40.67026816374424,FAS;APOL1;ICAM1;IDO1
775,KEGG_2019_Human,Cellular senescence,8 of 160,0.0058461676405623,0.0354208980575248,0,0,3.1212605983042714,16.049425039483662,HLA-B;HLA-C;CALM3;NBN;HLA-A;HLA-F;HLA-E;GADD45G
776,KEGG_2019_Human,Prolactin signaling pathway,5 of 70,0.0065268434522219,0.0384151357473635,0,0,4.540778498609824,22.8484338470438,SOCS1;STAT1;IRF1;STAT3;JAK2
777,KEGG_2019_Human,C-type lectin receptor signaling pathway,6 of 104,0.008352217057313,0.0465015328055807,0,0,3.618903754855416,17.317280516204846,CYLD;STAT1;IRF1;STAT2;CALM3;IRF9
778,KEGG_2019_Human,Toll-like receptor signaling pathway,6 of 104,0.008352217057313,0.0465015328055807,0,0,3.618903754855416,17.317280516204846,CXCL10;CD40;CXCL9;STAT1;IRF7;TLR3
779,KEGG_2019_Human,Endocytosis,10 of 244,0.008665725632839,0.0469773547464432,0,0,2.5391411171227687,12.056805923582818,UBB;HLA-B;HLA-C;HLA-A;ARPC5;HLA-F;PML;HLA-E;SNX6;CHMP5
948,Reactome_2022,Interferon Signaling R-HSA-913531,55 of 200,2.953828651807483e-51,2.3985088652676757e-48,0,0,26.25311812179017,3054.5171506348283,IFITM3;CIITA;IFIT5;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;TRIM25;JAK2;B2M;TRIM21;TRIM22;RSAD2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;TRIM14;KPNB1;IRF9;SP100;IFI6;SAMHD1;USP18;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;STAT1;STAT2;MX1;EIF2AK2;ISG15;PSMB8;PML;BST2;ISG20;HLA-DRA;TRIM38;XAF1
949,Reactome_2022,Cytokine Signaling In Immune System R-HSA-1280215,81 of 702,1.188373433278335e-44,4.824796139110039e-42,0,0,9.70210597826087,981.2822393306786,IFITM3;CD40;CIITA;CSF1;IFIT5;UBE2L6;ADAR;IFI35;IFIT1;IFI30;IFIT3;IFIT2;ICAM1;IL18BP;HERC5;MT2A;CASP3;TRIM25;JAK2;B2M;TRIM21;TRIM22;RSAD2;RIPK2;GSTO1;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;RBX1;PSMA3;PSMA4;IFI27;OAS1;PSMA2;IRF1;OAS3;IRF2;PSME1;IRF7;TRIM14;PSME2;IRF9;KPNB1;SP100;CEBPD;IFI6;NLRC5;SAMHD1;USP18;PSMB10;SOCS1;PSMB2;UBB;PSMB3;UBC;TNFRSF14;GBP2;GBP1;N4BP1;GBP4;MCL1;GSDMD;STAT1;STAT2;MX1;STAT3;EIF2AK2;ISG15;PML;PSMB8;PSMB9;BST2;ISG20;CXCL10;BCL6;HNRNPA2B1;HLA-DRA;TRIM38;XAF1
950,Reactome_2022,Immune System R-HSA-168256,124 of 1943,9.009464803786907e-42,2.438561806891657e-39,0,0,5.710861098421203,539.7351855969555,IFITM3;CSF1;TMEM179B;IFIT5;RNF19B;UBE2L6;IFI35;IFIT1;IFI30;IFIT3;IFIT2;ICAM1;HERC5;MT2A;RNF114;DHX58;TRIM25;FBXO6;B2M;TRIM21;TRIM22;HERC6;PDIA3;RSAD2;HLA-B;HLA-C;LMO7;HLA-A;HLA-F;HLA-E;RBX1;IFI27;PSME1;TRIM14;SERPING1;PSME2;TXNIP;RBCK1;KPNB1;CD274;UBA6;GNS;RNF213;SOCS1;UBB;DHX36;UBC;TNFRSF14;N4BP1;MCL1;GSDMD;RAB27A;EIF2AK2;ISG15;ARPC5;BST2;ISG20;CYLD;CXCL10;BCL6;HLA-DRA;XAF1;LGMN;CD40;CIITA;YWHAB;ADAR;CTSS;IL18BP;IFIH1;CTSO;CASP3;MUC13;TRIM69;JAK2;BTN3A1;DTX3L;DYNLT1;RIPK2;GSTO1;BTN3A3;BTN3A2;TAPBP;VAMP8;PSMA3;PSMA4;OAS1;PSMA2;IRF1;OAS3;IRF2;TAX1BP1;IRF7;CD47;TLR3;IRF9;TRIM56;SP100;CEBPD;UNC93B1;IFI6;NLRC5;SAMHD1;USP18;PSMB10;PSMB2;PSMB3;GBP2;GBP1;GBP4;CHGA;CD74;ERAP2;STAT1;STAT2;MX1;STAT3;PML;PSMB8;PSMB9;ERP44;HNRNPA2B1;TRIM38;CD68
951,Reactome_2022,Interferon Alpha/Beta Signaling R-HSA-909733,34 of 72,2.0874596702432895e-41,4.2375431305938774e-39,0,0,57.951189855827685,5428.290327177294,IFITM3;IFIT5;IFI6;ADAR;IFI35;IFIT1;SAMHD1;USP18;IFIT3;IFIT2;SOCS1;GBP2;RSAD2;STAT1;STAT2;MX1;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PSMB8;HLA-E;BST2;ISG20;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;XAF1;IRF9;KPNB1
952,Reactome_2022,Interferon Gamma Signaling R-HSA-877300,30 of 89,3.1354449383793686e-31,5.091962579928094e-29,0,0,32.46949704632032,2280.5719736163464,CIITA;SP100;IFI30;ICAM1;MT2A;SOCS1;TRIM25;JAK2;GBP2;B2M;TRIM21;GBP1;TRIM22;GBP4;STAT1;HLA-B;HLA-C;HLA-A;HLA-F;PML;HLA-E;OAS1;IRF1;OAS3;IRF2;IRF7;TRIM14;HLA-DRA;TRIM38;IRF9
953,Reactome_2022,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,38 of 378,7.750959138374227e-19,1.0489631367266455e-16,0,0,7.2228408420224275,301.2018540433453,UBA6;RNF19B;UBE2L6;PSMB10;CTSS;HERC5;RNF114;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;TRIM69;FBXO6;B2M;TRIM21;HERC6;PDIA3;DTX3L;ERAP2;HLA-B;HLA-C;LMO7;HLA-A;HLA-F;PSMB8;PSMB9;HLA-E;RBX1;TAPBP;VAMP8;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1
954,Reactome_2022,Adaptive Immune System R-HSA-1280218,52 of 733,1.107262358638996e-18,1.2844243360212352e-16,0,0,5.085730478913878,210.2677011204786,CD40;YWHAB;RNF19B;UBE2L6;IFI30;CTSS;ICAM1;HERC5;CTSO;RNF114;TRIM69;FBXO6;B2M;TRIM21;HERC6;PDIA3;BTN3A1;DTX3L;RIPK2;HLA-B;HLA-C;BTN3A3;LMO7;HLA-A;BTN3A2;HLA-F;HLA-E;RBX1;TAPBP;VAMP8;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1;CD274;UBA6;PSMB10;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;TNFRSF14;CD74;ERAP2;PSMB8;PSMB9;HLA-DRA;LGMN
955,Reactome_2022,ER-Phagosome Pathway R-HSA-1236974,21 of 89,1.4187770076637554e-18,1.4400586627787115e-16,0,0,19.149990692479523,787.0021202327879,PDIA3;HLA-B;HLA-C;HLA-A;HLA-F;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;VAMP8;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M
956,Reactome_2022,Antigen processing-Cross Presentation R-HSA-1236975,22 of 104,2.6857220104918573e-18,2.4231180805770983e-16,0,0,16.677584204413474,674.7514093781632,PDIA3;HLA-B;HLA-C;HLA-A;HLA-F;CTSS;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;VAMP8;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M
957,Reactome_2022,Innate Immune System R-HSA-168249,54 of 1035,1.0988937269213035e-13,8.923017062600983e-12,0,0,3.6338055564560574,108.43022227312692,TMEM179B;UBE2L6;CTSS;HERC5;IFIH1;DHX58;MUC13;TRIM25;B2M;TRIM21;DYNLT1;RIPK2;HLA-B;HLA-C;HLA-A;HLA-E;VAMP8;PSMA3;PSMA4;PSMA2;PSME1;TAX1BP1;IRF7;SERPING1;PSME2;TXNIP;CD47;TLR3;KPNB1;TRIM56;UNC93B1;NLRC5;GNS;USP18;PSMB10;SOCS1;PSMB2;UBB;PSMB3;DHX36;UBC;N4BP1;CHGA;GSDMD;RAB27A;ISG15;ARPC5;PSMB8;PSMB9;BST2;CYLD;ERP44;CD68;LGMN
958,Reactome_2022,Programmed Cell Death R-HSA-5357801,24 of 208,1.2820472672613745e-13,9.463839827420329e-12,0,0,8.117377413529656,240.96554973959528,GSDMD;MLKL;YWHAB;STAT3;CFLAR;PSMB8;PSMB10;PSMB9;PSMA3;CASP7;PSMA4;PSMB2;UBB;PSMA2;PSMB3;CASP3;IRF1;UBC;IRF2;TNFSF10;PSME1;NMT1;PSME2;KPNB1
959,Reactome_2022,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,14 of 53,1.5098613518224738e-13,1.0216728480665407e-11,0,0,21.80963721520997,643.8551326346461,APOBEC3G;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
960,Reactome_2022,Interleukin-1 Family Signaling R-HSA-446652,20 of 152,1.2469455509390365e-12,7.788613748942288e-11,0,0,9.335149603288404,255.8794762809274,GSDMD;RIPK2;STAT3;NLRC5;USP18;PSMB10;PSMB8;RBX1;IL18BP;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;N4BP1
961,Reactome_2022,Signaling By Interleukins R-HSA-449147,33 of 453,1.755597254240772e-12,1.0155814644107032e-10,0,0,4.973519736842105,134.62428662848873,CSF1;CEBPD;NLRC5;USP18;PSMB10;ICAM1;IL18BP;SOCS1;PSMB2;UBB;PSMB3;CASP3;UBC;JAK2;N4BP1;MCL1;GSDMD;RIPK2;STAT1;GSTO1;STAT2;STAT3;PSMB8;PSMB9;RBX1;CXCL10;PSMA3;PSMA4;BCL6;PSMA2;HNRNPA2B1;PSME1;PSME2
962,Reactome_2022,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,13 of 51,1.8760741337636143e-12,1.0155814644107032e-10,0,0,20.72165367121508,559.5227717684413,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
963,Reactome_2022,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,27 of 307,2.6583755375352687e-12,1.349125585299149e-10,0,0,6.029274193548387,160.70008931420924,UBA6;RNF19B;UBE2L6;PSMB10;HERC5;RNF114;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;TRIM69;FBXO6;TRIM21;HERC6;DTX3L;LMO7;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMA2;PSME1;PSME2;RBCK1
964,Reactome_2022,Apoptosis R-HSA-109581,21 of 178,2.921115427796532e-12,1.395262192571049e-10,0,0,8.256591147303071,219.28726315588492,GSDMD;YWHAB;STAT3;CFLAR;PSMB10;PSMB8;PSMB9;CASP7;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;CASP3;UBC;TNFSF10;PSME1;NMT1;PSME2;KPNB1
965,Reactome_2022,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,13 of 53,3.2155429139088024e-12,1.4505671367188598e-10,0,0,19.68356481481481,520.886665883565,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
966,Reactome_2022,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,13 of 54,4.171471662936149e-12,1.7827552580548175e-10,0,0,19.202499247214693,503.15832988717256,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
967,Reactome_2022,Degradation Of DVL R-HSA-4641258,13 of 55,5.38056578834381e-12,2.184509710067587e-10,0,0,18.74434156378601,486.3824407749474,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
968,Reactome_2022,Host Interactions Of HIV Factors R-HSA-162909,18 of 130,7.060427260091574e-12,2.7300318739020746e-10,0,0,9.849921630094045,252.91166587999703,APOBEC3G;HLA-A;RANGAP1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M;KPNB1
969,Reactome_2022,Interleukin-1 Signaling R-HSA-9020702,17 of 114,8.056484810544557e-12,2.973575302800991e-10,0,0,10.715914948453609,273.7331585678052,RIPK2;NLRC5;USP18;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;N4BP1
970,Reactome_2022,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,14 of 72,1.4067219386242988e-11,4.4112816037505044e-10,0,0,14.650902103128002,366.08463851770085,STAT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
971,Reactome_2022,Degradation Of GLI1 By Proteasome R-HSA-5610780,13 of 59,1.4124793312501615e-11,4.4112816037505044e-10,0,0,17.110909822866343,427.48339104765336,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
972,Reactome_2022,Degradation Of GLI2 By Proteasome R-HSA-5610783,13 of 59,1.4124793312501615e-11,4.4112816037505044e-10,0,0,17.110909822866343,427.48339104765336,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
973,Reactome_2022,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,13 of 59,1.4124793312501615e-11,4.4112816037505044e-10,0,0,17.110909822866343,427.48339104765336,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
974,Reactome_2022,Cellular Response To Hypoxia R-HSA-1234174,14 of 73,1.714313103682624e-11,5.150621535836553e-10,0,0,14.401847090308022,357.0134873545818,MIA3;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
975,Reactome_2022,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,13 of 60,1.7760763916677768e-11,5.150621535836553e-10,0,0,16.745994221171525,414.53083271312863,ERLIN1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
976,Reactome_2022,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,12 of 49,2.273508546496319e-11,6.365823930189692e-10,0,0,19.585197505197502,479.9766242871845,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
977,Reactome_2022,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,12 of 51,3.7956130913793595e-11,9.339508576363756e-10,0,0,18.578934911242605,445.7939271831887,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
978,Reactome_2022,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,12 of 51,3.7956130913793595e-11,9.339508576363756e-10,0,0,18.578934911242605,445.7939271831887,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
979,Reactome_2022,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,12 of 51,3.7956130913793595e-11,9.339508576363756e-10,0,0,18.578934911242605,445.7939271831887,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
980,Reactome_2022,Vpu Mediated Degradation Of CD4 R-HSA-180534,12 of 51,3.7956130913793595e-11,9.339508576363756e-10,0,0,18.578934911242605,445.7939271831887,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
981,Reactome_2022,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,13 of 64,4.250428884430535e-11,1.0151024276934102e-09,0,0,15.429435971919633,368.4767811136687,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
982,Reactome_2022,Regulation Of Apoptosis R-HSA-169911,12 of 52,4.860403864522699e-11,1.127613696569266e-09,0,0,18.11353846153846,430.1478943507418,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
983,Reactome_2022,Regulation Of RAS By GAPs R-HSA-5658442,13 of 65,5.2332311780425584e-11,1.1803843657140435e-09,0,0,15.131944444444445,358.2246813438692,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
984,Reactome_2022,Signaling By NOTCH4 R-HSA-9013694,14 of 81,7.487771267565317e-11,1.5523010448729623e-09,0,0,12.677048195554734,295.5674682468241,PSENEN;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
985,Reactome_2022,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,12 of 54,7.837973256131952e-11,1.5523010448729623e-09,0,0,17.24923076923077,401.380211851572,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
986,Reactome_2022,Degradation Of AXIN R-HSA-4641257,12 of 54,7.837973256131952e-11,1.5523010448729623e-09,0,0,17.24923076923077,401.380211851572,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
987,Reactome_2022,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,12 of 54,7.837973256131952e-11,1.5523010448729623e-09,0,0,17.24923076923077,401.380211851572,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
988,Reactome_2022,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,12 of 54,7.837973256131952e-11,1.5523010448729623e-09,0,0,17.24923076923077,401.380211851572,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
989,Reactome_2022,Hh Mutants Are Degraded By ERAD R-HSA-5362768,12 of 55,9.875199767071576e-11,1.9092052883005047e-09,0,0,16.84722719141324,388.1333186851206,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
990,Reactome_2022,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,14 of 83,1.0536869247144574e-10,1.989752983414278e-09,0,0,12.30834118544443,282.766360066878,STAT1;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;HERC5;OAS1;UBB;OAS3;UBC;TRIM25;KPNB1
991,Reactome_2022,Endosomal/Vacuolar Pathway R-HSA-1236977,7 of 11,1.1286430774222948e-10,2.0828594974247806e-09,0,0,104.25227272727273,2387.88108801391,HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
992,Reactome_2022,Orc1 Removal From Chromatin R-HSA-68949,13 of 69,1.1594101020405445e-10,2.092091117459827e-09,0,0,14.048225308641976,321.3944499141649,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
993,Reactome_2022,Stabilization Of P53 R-HSA-69541,12 of 56,1.2380249546314548e-10,2.18538318078422e-09,0,0,16.463496503496504,375.5707744382464,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
994,Reactome_2022,Infectious Disease R-HSA-5663205,46 of 961,1.6388951548205062e-10,2.8314529057750023e-09,0,0,3.23890860608792,72.97853356738241,CEBPD;YWHAB;PSMB10;IFIH1;RNF213;PSMB2;UBB;PSMB3;UBC;TRIM25;JAK2;B2M;CHGA;GSDMD;APOBEC3G;RIPK2;STAT1;STAT2;RHBDF2;HLA-B;HLA-C;EIF2AK2;ISG15;HLA-A;ARPC5;HLA-F;PARP14;PARP9;ATP1B1;RANGAP1;PML;PSMB8;PSMB9;HLA-E;RBX1;PARP10;PSMA3;PSMA4;PSMA2;PSME1;NMT1;IRF7;PSME2;TXNIP;KPNB1;CHMP5
995,Reactome_2022,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,12 of 58,1.9184879551124588e-10,3.179208611329218e-09,0,0,15.746086956521738,352.3078871844162,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
996,Reactome_2022,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,12 of 58,1.9184879551124588e-10,3.179208611329218e-09,0,0,15.746086956521738,352.3078871844162,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
997,Reactome_2022,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,10 of 35,2.040044388681197e-10,3.313032087218264e-09,0,0,24.022018348623853,536.0003974725468,HERC5;IFIH1;CYLD;UBB;UBC;NLRC5;TAX1BP1;TRIM25;UBE2L6;ISG15
998,Reactome_2022,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,12 of 59,2.3722598318059936e-10,3.639256042558486e-09,0,0,15.410278232405892,341.5227081369045,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
999,Reactome_2022,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,12 of 59,2.3722598318059936e-10,3.639256042558486e-09,0,0,15.410278232405892,341.5227081369045,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1000,Reactome_2022,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,14 of 88,2.375376480980293e-10,3.639256042558486e-09,0,0,11.473767885532592,254.26667045958555,YWHAB;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;XRN1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1001,Reactome_2022,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,12 of 61,3.5818299835453316e-10,5.386011012294091e-09,0,0,14.77978021978022,321.45988119824426,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1002,Reactome_2022,Asymmetric Localization Of PCP Proteins R-HSA-4608870,12 of 62,4.3749851192004535e-10,6.4590689396195796e-09,0,0,14.483446153846154,312.11750874550864,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1003,Reactome_2022,ABC Transporter Disorders R-HSA-5619084,13 of 77,4.883491680372116e-10,7.081062936539568e-09,0,0,12.287181712962964,263.4370586774166,ERLIN1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1004,Reactome_2022,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",9 of 28,5.127939357881848e-10,7.305064488772038e-09,0,0,28.369062901155328,606.8467957943614,PDIA3;ERAP2;HLA-B;HLA-C;HLA-A;HLA-F;B2M;HLA-E;TAPBP
1005,Reactome_2022,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,12 of 63,5.323499152337166e-10,7.452898813272035e-09,0,0,14.198733031674209,303.19577103804204,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1006,Reactome_2022,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,13 of 78,5.77220622584433e-10,7.944121110823047e-09,0,0,12.09753086419753,257.3483129645389,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1007,Reactome_2022,Downstream TCR Signaling R-HSA-202424,14 of 94,5.876417235696884e-10,7.952751325643115e-09,0,0,10.60998452012384,225.5141988877729,RIPK2;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;HLA-DRA
1008,Reactome_2022,Hedgehog Ligand Biogenesis R-HSA-5358346,12 of 64,6.45393173059072e-10,8.59113535285191e-09,0,0,13.924970414201184,294.6685466230276,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1009,Reactome_2022,p53-Dependent G1 DNA Damage Response R-HSA-69563,12 of 65,7.79673398534581e-10,1.0211206445323869e-08,0,0,13.66153846153846,286.51177925136733,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1010,Reactome_2022,Activation Of NF-kappaB In B Cells R-HSA-1169091,12 of 66,9.386724547634618e-10,1.2098444972506842e-08,0,0,13.407863247863247,278.70328041237707,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1011,Reactome_2022,Cyclin E Associated Events During G1/S Transition R-HSA-69202,13 of 82,1.0992693379820687e-09,1.3650825539055071e-08,0,0,11.39389872964752,235.04040853457656,MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1012,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,12 of 67,1.1263612205870562e-09,1.3650825539055071e-08,0,0,13.163412587412587,271.2225539192333,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1013,Reactome_2022,G1/S DNA Damage Checkpoints R-HSA-69615,12 of 67,1.1263612205870562e-09,1.3650825539055071e-08,0,0,13.163412587412587,271.2225539192333,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1014,Reactome_2022,Regulation Of PTEN Stability And Activity R-HSA-8948751,12 of 67,1.1263612205870562e-09,1.3650825539055071e-08,0,0,13.163412587412587,271.2225539192333,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1015,Reactome_2022,KEAP1-NFE2L2 Pathway R-HSA-9755511,14 of 100,1.3603750582994086e-09,1.6009051410711884e-08,0,0,9.866729066167473,201.43426050164047,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TRIM21
1016,Reactome_2022,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,14 of 100,1.3603750582994086e-09,1.6009051410711884e-08,0,0,9.866729066167473,201.43426050164047,CD40;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TNFRSF14
1017,Reactome_2022,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,13 of 84,1.4961260064335675e-09,1.7110624186254326e-08,0,0,11.071813597635192,224.9835341290255,MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1018,Reactome_2022,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,13 of 84,1.4961260064335675e-09,1.7110624186254326e-08,0,0,11.071813597635192,224.9835341290255,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1019,Reactome_2022,Hedgehog On State R-HSA-5632684,13 of 85,1.739748723706679e-09,1.962049949513644e-08,0,0,10.917481138545954,220.2004103528218,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1020,Reactome_2022,ABC-family Proteins Mediated Transport R-HSA-382556,14 of 102,1.7758672178544234e-09,1.9753481930106742e-08,0,0,9.641500140726148,194.26636419429687,ABCB1;ERLIN1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1021,Reactome_2022,Cellular Response To Chemical Stress R-HSA-9711123,18 of 182,1.965123732484253e-09,2.1563249605097483e-08,0,0,6.708884471289854,134.4977744998078,HM13;STAT3;PSMB10;PSMB8;RBX1;PSMB9;HELZ2;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TXNIP;TRIM21
1022,Reactome_2022,HIV Infection R-HSA-162906,20 of 229,2.200770763888921e-09,2.382701147037072e-08,0,0,5.872639729521682,117.06789115729453,APOBEC3G;HLA-A;RANGAP1;PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;NMT1;PSME2;B2M;KPNB1;CHMP5
1023,Reactome_2022,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,12 of 72,2.676041739101536e-09,2.8220076521434384e-08,0,0,12.063384615384615,238.11826946892884,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1024,Reactome_2022,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,12 of 72,2.676041739101536e-09,2.8220076521434384e-08,0,0,12.063384615384615,238.11826946892884,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1025,Reactome_2022,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,12 of 73,3.154564432722696e-09,3.24241306249472e-08,0,0,11.86501891551072,232.25080906024175,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1026,Reactome_2022,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,12 of 73,3.154564432722696e-09,3.24241306249472e-08,0,0,11.86501891551072,232.25080906024175,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1027,Reactome_2022,MAPK6/MAPK4 Signaling R-HSA-5687128,13 of 90,3.5880862706470317e-09,3.596945742920234e-08,0,0,10.20594837261504,198.4612678111909,PSMB10;PSMB8;PSMB9;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1028,Reactome_2022,Switching Of Origins To A Post-Replicative State R-HSA-69052,13 of 90,3.5880862706470317e-09,3.596945742920234e-08,0,0,10.20594837261504,198.4612678111909,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1029,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,12 of 75,4.349187814057406e-09,4.254868078330861e-08,0,0,11.487179487179487,221.16584538392937,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1030,Reactome_2022,ISG15 Antiviral Mechanism R-HSA-1169408,12 of 75,4.349187814057406e-09,4.254868078330861e-08,0,0,11.487179487179487,221.16584538392937,HERC5;UBB;STAT1;UBC;MX1;TRIM25;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;KPNB1
1031,Reactome_2022,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,12 of 76,5.087404943100325e-09,4.9178247783303136e-08,0,0,11.307115384615384,215.9263059974019,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1032,Reactome_2022,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,10 of 48,5.985533290002201e-09,5.7179447429197496e-08,0,0,15.793497505230969,299.03282456180943,PSMA3;PSMA4;PSMB2;PSMB3;PSMA2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1033,Reactome_2022,FCERI Mediated NF-kB Activation R-HSA-2871837,12 of 78,6.9108974235962156e-09,6.525172916232708e-08,0,0,10.963356643356644,206.00329491235885,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1034,Reactome_2022,UCH Proteinases R-HSA-5689603,13 of 95,7.064580914195994e-09,6.593608853249596e-08,0,0,9.581187895212285,179.8213837340897,USP15;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1035,Reactome_2022,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,12 of 79,8.02679769298248e-09,7.406545143979289e-08,0,0,10.799173363949484,201.30177706653336,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1036,Reactome_2022,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,10 of 50,9.123824954047664e-09,8.324208834479442e-08,0,0,15.002293577981652,277.72811034856124,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1037,Reactome_2022,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,12 of 80,9.302064138238269e-09,8.392528978054972e-08,0,0,10.639819004524886,196.7624868430832,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1038,Reactome_2022,TCR Signaling R-HSA-202403,14 of 116,9.77935706428648e-09,8.7261955342864e-08,0,0,8.312207855278334,153.3019837661359,RIPK2;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;HLA-DRA
1039,Reactome_2022,Hedgehog Off State R-HSA-5610787,13 of 98,1.0396443343787585e-08,9.175991299082085e-08,0,0,9.24161220043573,169.8774863266026,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1040,Reactome_2022,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,12 of 81,1.0756514196271089e-08,9.391709169217337e-08,0,0,10.485083612040134,192.3777378673661,HERC5;IFIH1;CYLD;UBB;DHX58;UBC;IRF7;TAX1BP1;NLRC5;TRIM25;UBE2L6;ISG15
1041,Reactome_2022,Transcriptional Regulation By RUNX2 R-HSA-8878166,14 of 119,1.364973753248846e-08,1.1791049868490033e-07,0,0,8.073477812177503,146.2070141372093,STAT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1042,Reactome_2022,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,12 of 87,2.4644506676235e-08,2.1064567811687177e-07,0,0,9.643323076923076,168.93859791568727,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1043,Reactome_2022,PCP/CE Pathway R-HSA-4086400,12 of 88,2.810917374979795e-08,2.377567613003744e-07,0,0,9.515951417004048,165.45546353298622,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1044,Reactome_2022,Mitotic G1 Phase And G1/S Transition R-HSA-453279,15 of 147,2.9156926962231996e-08,2.440765432302307e-07,0,0,6.89264539808018,119.59134935326767,MAX;PPP2R2A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2
1045,Reactome_2022,Metabolism Of Polyamines R-HSA-351202,10 of 58,4.1130375212534194e-08,3.407945374752833e-07,0,0,12.496814475025484,212.52731196103437,PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1046,Reactome_2022,Assembly Of Pre-Replicative Complex R-HSA-68867,13 of 110,4.279011651116134e-08,3.509654000713436e-07,0,0,8.093356242840779,137.31964098443592,PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1047,Reactome_2022,Transcriptional Regulation By RUNX3 R-HSA-8878159,12 of 95,6.732674285134189e-08,5.46693151952896e-07,0,0,8.710287303058388,143.83914383162522,PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1048,Reactome_2022,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,12 of 98,9.564163300838773e-08,7.689208515129786e-07,0,0,8.40515205724508,135.84959494502627,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1049,Reactome_2022,PTEN Regulation R-HSA-6807070,14 of 139,9.98967119497668e-08,7.952561774824571e-07,0,0,6.7747863777089785,109.20365601178388,PSMB10;PML;PSMB8;PSMB9;MOV10;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1050,Reactome_2022,CLEC7A (Dectin-1) Signaling R-HSA-5607764,12 of 99,1.0720771703618287e-07,8.451715168289367e-07,0,0,8.308116710875332,133.3327911251017,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1051,Reactome_2022,Synthesis Of DNA R-HSA-69239,13 of 119,1.1001593196591722e-07,8.589705457338921e-07,0,0,7.402777777777778,118.61204811247732,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1052,Reactome_2022,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,13 of 121,1.3412182064579457e-07,1.037208746327478e-06,0,0,7.264946273433928,114.9642682831226,RIPK2;STAT1;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;HLA-E;IFIH1;IRF7;TRIM25;B2M
1053,Reactome_2022,DNA Replication Pre-Initiation R-HSA-69002,13 of 127,2.374592323923465e-07,1.8190273273828805e-06,0,0,6.8804689192116095,104.94964933456689,PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1054,Reactome_2022,G1/S Transition R-HSA-69206,13 of 129,2.851825654964799e-07,2.1641891886274923e-06,0,0,6.7611483610046825,101.89142721689116,MAX;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1055,Reactome_2022,Signaling By B Cell Receptor (BCR) R-HSA-983705,12 of 109,3.126648308621145e-07,2.350776320926268e-06,0,0,7.447803330689928,111.554196650726,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1056,Reactome_2022,Ub-specific Processing Proteases R-HSA-5689880,16 of 201,3.257268221668556e-07,2.426515409169603e-06,0,0,5.247924560074093,78.3893342970233,USP15;USP18;PSMB8;PSMB10;PSMB9;IFIH1;CYLD;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1057,Reactome_2022,SARS-CoV Infections R-HSA-9679506,22 of 369,3.441785250785135e-07,2.5320729110248955e-06,0,0,3.887763597273684,57.85810741473362,RIPK2;STAT1;YWHAB;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PARP14;PARP9;ATP1B1;HLA-E;RBX1;PARP10;IFIH1;UBB;UBC;IRF7;TRIM25;JAK2;B2M
1058,Reactome_2022,Disease R-HSA-1643685,58 of 1736,3.461331196105461e-07,2.5320729110248955e-06,0,0,2.2281389775334177,33.14678115206012,YWHAB;IFIH1;MUC13;TRIM25;JAK2;B2M;PSENEN;RIPK2;RHBDF2;HLA-B;HLA-C;AP3B1;LMO7;HLA-A;HLA-F;PARP9;ATP1B1;RANGAP1;HLA-E;RBX1;ETV6;BTC;PSMA3;PSMA4;PSMA2;PSME1;IRF7;SERPING1;PSME2;TXNIP;TLR3;KPNB1;CHMP5;CEBPD;UNC93B1;GNS;PSMB10;RNF213;PSMB2;UBB;PSMB3;UBC;CHGA;GSDMD;APOBEC3G;STAT1;STAT2;STAT3;ERLIN1;EIF2AK2;ISG15;ARPC5;PARP14;PML;PSMB8;PSMB9;PARP10;NMT1
1059,Reactome_2022,SARS-CoV-2 Infection R-HSA-9694516,19 of 283,3.694399521529125e-07,2.6769000585494603e-06,0,0,4.3903778349533065,65.02710497393167,RIPK2;STAT1;YWHAB;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PARP14;PARP9;HLA-E;PARP10;IFIH1;UBB;UBC;IRF7;TRIM25;B2M
1060,Reactome_2022,Signaling By NOTCH R-HSA-157118,16 of 203,3.725242692316368e-07,2.6769000585494603e-06,0,0,5.191263931230946,76.84609126611396,PSENEN;STAT1;PSMB8;PSMB10;PSMB9;RBX1;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1061,Reactome_2022,DNA Replication R-HSA-69306,14 of 155,3.873522626786095e-07,2.759035414868692e-06,0,0,6.001097863557517,88.59979669288275,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1062,Reactome_2022,Regulated Necrosis R-HSA-5218859,9 of 57,4.346264162803113e-07,3.068840434953155e-06,0,0,11.212842987804878,164.2544587554737,GSDMD;UBB;MLKL;CASP3;IRF1;IRF2;UBC;TNFSF10;CFLAR
1063,Reactome_2022,Signaling By Hedgehog R-HSA-5358351,13 of 135,4.84104179377349e-07,3.388729255641443e-06,0,0,6.426659583080348,93.4498366064929,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1064,Reactome_2022,G2/M Transition R-HSA-69275,15 of 182,4.885876127687984e-07,3.390881551865507e-06,0,0,5.438315914754342,79.02823114756441,PPP2R2A;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;OPTN
1065,Reactome_2022,Mitotic G2-G2/M Phases R-HSA-453274,15 of 184,5.621445760584072e-07,3.86831691321548e-06,0,0,5.373405858355691,77.33140677431702,PPP2R2A;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;OPTN
1066,Reactome_2022,S Phase R-HSA-69242,14 of 161,6.161487279341309e-07,4.204308967079952e-06,0,0,5.754385964912281,82.28643872354397,MAX;PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1067,Reactome_2022,C-type Lectin Receptors (CLRs) R-HSA-5621481,13 of 141,7.989307846382635e-07,5.406098309385583e-06,0,0,6.12352912808642,85.97429704561941,PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;MUC13
1068,Reactome_2022,Beta-catenin Independent WNT Signaling R-HSA-3858494,13 of 142,8.662784400159802e-07,5.813372671842776e-06,0,0,6.075748875490477,84.81173979144482,PSMB10;PSMB8;PSMB9;MOV10;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1069,Reactome_2022,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,23 of 424,9.659818044943663e-07,6.429321518437913e-06,0,0,3.518480867893959,48.73138518947251,PSENEN;STAT1;YWHAB;STAT3;AP3B1;LMO7;PSMB10;PSMB8;PSMB9;RBX1;ETV6;BTC;PSMA3;RNF213;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2
1070,Reactome_2022,Deubiquitination R-HSA-5688426,18 of 279,1.335367432591701e-06,8.815596384263911e-06,0,0,4.1945735596151765,56.73707742633373,USP15;RIPK2;USP18;PSMB8;PSMB10;PSMB9;IFIH1;CYLD;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;TRIM25;PSME2
1071,Reactome_2022,G2/M Checkpoints R-HSA-69481,13 of 148,1.3876598650792176e-06,9.086933955196168e-06,0,0,5.803932327389117,78.28281112961675,YWHAB;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1072,Reactome_2022,Regulation Of TNFR1 Signaling R-HSA-5357905,7 of 35,1.6240546548386648e-06,1.0549859037831968e-05,0,0,14.875,198.292446852215,CYLD;UBB;SPPL2A;UBC;TAX1BP1;CFLAR;RBCK1
1073,Reactome_2022,Transcriptional Regulation By RUNX1 R-HSA-8878171,15 of 204,2.070118951205892e-06,1.3340766574437966e-05,0,0,4.799861973775017,62.82013506828981,PCGF5;PSMB8;PSMB10;PML;PSMB9;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1074,Reactome_2022,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,12 of 130,2.0971732579725297e-06,1.3408698310816487e-05,0,0,6.115775749674055,79.96327981243044,PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1075,Reactome_2022,Neddylation R-HSA-8951664,16 of 237,2.8954323971394097e-06,1.836789926935313e-05,0,0,4.384939597693858,55.918398917301865,LMO7;PSMB8;PSMB10;PSMB9;RBX1;NUB1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;FBXO6
1076,Reactome_2022,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,6 of 25,2.9581691845028537e-06,1.862041378152184e-05,0,0,18.741294323421847,238.59429354893217,SOCS1;UBB;STAT1;UBC;STAT3;JAK2
1077,Reactome_2022,Toll-like Receptor Cascades R-HSA-168898,13 of 162,3.81818028828232e-06,2.384894149296341e-05,0,0,5.254826414781672,65.55783029873047,GSDMD;RIPK2;UNC93B1;NLRC5;USP18;CTSS;SOCS1;UBB;UBC;IRF7;N4BP1;TLR3;LGMN
1078,Reactome_2022,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,13 of 167,5.337823060576372e-06,3.3086353627389424e-05,0,0,5.082912457912458,61.71007794210589,PSMB10;PSMB8;RBX1;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1079,Reactome_2022,SARS-CoV-2-host Interactions R-HSA-9705683,14 of 196,6.341269083213891e-06,3.900841284522485e-05,0,0,4.639437961419386,55.52679608320386,RIPK2;STAT1;YWHAB;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;HLA-E;IFIH1;IRF7;TRIM25;B2M
1080,Reactome_2022,Separation Of Sister Chromatids R-HSA-2467813,13 of 170,6.486836067114432e-06,3.960384125185654e-05,0,0,4.985020051899033,59.549731775052535,RANGAP1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1081,Reactome_2022,TNF Signaling R-HSA-75893,7 of 44,8.126072515642095e-06,4.924157375150284e-05,0,0,11.251597051597052,131.873587546996,CYLD;UBB;SPPL2A;UBC;TAX1BP1;CFLAR;RBCK1
1082,Reactome_2022,Signaling By CSF3 (G-CSF) R-HSA-9674555,6 of 30,9.237875679711333e-06,5.5564111495745205e-05,0,0,14.83308157099698,171.94802747344656,SOCS1;UBB;STAT1;UBC;STAT3;JAK2
1083,Reactome_2022,Regulation Of NF-kappa B Signaling R-HSA-9758274,5 of 18,9.43255645390957e-06,5.605402330006327e-05,0,0,22.764133456904545,263.4116054351783,UBB;UBC;NLRC5;USP18;N4BP1
1084,Reactome_2022,Disorders Of Transmembrane Transporters R-HSA-5619115,13 of 176,9.4573906306757e-06,5.605402330006327e-05,0,0,4.800045444217224,55.53035314620151,ERLIN1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;UBB;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1085,Reactome_2022,Mitotic Anaphase R-HSA-68882,15 of 232,9.95422143435535e-06,5.857121597606192e-05,0,0,4.174514125425766,48.08002418150941,PPP2R2A;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1086,Reactome_2022,Mitotic Metaphase And Anaphase R-HSA-2555396,15 of 233,1.0479384420368989e-05,6.121769891611237e-05,0,0,4.155151290671833,47.643382787303054,PPP2R2A;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1087,Reactome_2022,Nicotinamide Salvaging R-HSA-197264,5 of 19,1.2625078070735264e-05,7.322545281026452e-05,0,0,21.137048192771083,238.42221306473496,PARP10;NNMT;NAMPT;PARP14;PARP9
1088,Reactome_2022,RAF/MAP Kinase Cascade R-HSA-5673001,16 of 271,1.5780328528912372e-05,9.087678557075777e-05,0,0,3.7936350864333273,41.94526117376029,YWHAB;PSMB8;PSMB10;PSMB9;RBX1;BTC;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2
1089,Reactome_2022,MAPK1/MAPK3 Signaling R-HSA-5684996,16 of 277,2.0659957369758638e-05,0.00011814003791721135,0,0,3.705279239923133,39.97000749775376,YWHAB;PSMB8;PSMB10;PSMB9;RBX1;BTC;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2
1090,Reactome_2022,Death Receptor Signaling R-HSA-73887,11 of 139,2.4224548221687943e-05,0.0001375547773147595,0,0,5.149659700920245,54.7313251079079,PSENEN;CYLD;UBB;RIPK2;CASP3;SPPL2A;UBC;TNFSF10;TAX1BP1;RBCK1;CFLAR
1091,Reactome_2022,MAPK Family Signaling Cascades R-HSA-5683057,17 of 318,3.081409823756223e-05,0.00017375727617292036,0,0,3.417296511627907,35.497298184188224,YWHAB;PSMB8;PSMB10;PSMB9;RBX1;BTC;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2
1092,Reactome_2022,TCF Dependent Signaling In Response To WNT R-HSA-201681,13 of 198,3.307003481782276e-05,0.00018519219497980743,0,0,4.224457791124458,43.58323667703373,PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1093,Reactome_2022,TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,4 of 12,3.5224182393313825e-05,0.0001959043568724029,0,0,29.51201201201201,302.6096109881204,UBB;UBC;IRF7;TLR3
1094,Reactome_2022,Trafficking And Processing Of Endosomal TLR R-HSA-1679131,4 of 13,5.020455109935013e-05,0.0002773203775011721,0,0,26.231564898231564,259.6768814593538,UNC93B1;CTSS;TLR3;LGMN
1095,Reactome_2022,PIP3 Activates AKT Signaling R-HSA-1257604,15 of 268,5.355761464563687e-05,0.00029384312900173747,0,0,3.573883583335379,35.148260771273435,PSMB8;PSMB10;PML;PSMB9;BTC;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1096,Reactome_2022,Signaling By ROBO Receptors R-HSA-376176,13 of 209,5.785010373390691e-05,0.00031526365256330475,0,0,3.985119047619048,38.88541804065706,PSMB8;PSMB10;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1097,Reactome_2022,Infection With Mycobacterium Tuberculosis R-HSA-9635486,5 of 26,6.482436928271429e-05,0.0003509159190504267,0,0,14.086345381526105,135.84630547633412,RNF213;UBB;UBC;B2M;KPNB1
1098,Reactome_2022,Post-translational Protein Modification R-HSA-597592,43 of 1383,7.490247550020968e-05,0.0004027868218951672,0,0,1.9999213118083052,18.99789974990254,SP100;USP15;CSF1;UBA6;MIA3;USP18;PSMB10;IFIH1;NUB1;PSMB2;UBB;PSMB3;UBC;MUC13;TRIM25;FBXO6;APOL1;CHGA;PDIA3;RIPK2;GOLM1;TRAPPC4;HLA-B;SHISA5;RAB27A;LMO7;HLA-A;RANGAP1;PDIA6;PML;PSMB8;PSMB9;RBX1;CYLD;PSMA3;PSMA4;PSMA2;PSME1;PSME2;NUCB1;SCG3;TOP1;LY6E
1099,Reactome_2022,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,7 of 63,8.922462901943181e-05,0.00047664736028801727,0,0,7.426893939393939,69.25098409988244,UBB;DHX36;UBC;IRF7;TRIM21;TLR3;TRIM56
1100,Reactome_2022,Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,4 of 15,9.332140797492112e-05,0.0004952744004943525,0,0,21.46000546000546,199.13728422643885,UBB;UBC;TRIM21;TRIM56
1101,Reactome_2022,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,6 of 45,0.00010245599255942004,0.0005402225062223965,0,0,9.12107831745294,83.78692950262055,UBB;RIPK2;UBC;NLRC5;USP18;N4BP1
1102,Reactome_2022,Regulation Of Necroptotic Cell Death R-HSA-5675482,5 of 29,0.00011227783248273009,0.0005881909675869471,0,0,12.32366967871486,112.0780342685818,UBB;MLKL;UBC;TNFSF10;CFLAR
1103,Reactome_2022,Translation Of Structural Proteins R-HSA-9683701,5 of 30,0.00013288596554177374,0.0006916884873071814,0,0,11.830120481927713,105.59588255365142,PARP10;UBB;UBC;PARP14;PARP9
1104,Reactome_2022,Cellular Responses To Stimuli R-HSA-8953897,27 of 736,0.0001380935609208363,0.0007142163787752807,0,0,2.3283952864097546,20.69379734187793,HM13;MT1X;MIA3;PSMB10;HELZ2;MT2A;PSMB2;UBB;PSMB3;UBC;TRIM21;STAT3;PDIA6;PSMB8;PSMB9;RBX1;DNAJA1;MOV10;PSMA3;PSMA4;PSMA2;PSME1;PSME2;TXNIP;ATF3;MT1E;FKBP5
1105,Reactome_2022,DNA Damage Bypass R-HSA-73893,6 of 48,0.00014795425878043233,0.0007603725198082978,0,0,8.468277945619336,74.67841850792253,UBB;UBC;TRIM25;UBE2L6;ISG15;RBX1
1106,Reactome_2022,Nicotinate Metabolism R-HSA-196807,5 of 31,0.00015626929108657547,0.0007930666522643706,0,0,11.374536607970343,99.68564049919183,PARP10;NNMT;NAMPT;PARP14;PARP9
1107,Reactome_2022,RIPK1-mediated Regulated Necrosis R-HSA-5213460,5 of 31,0.00015626929108657547,0.0007930666522643706,0,0,11.374536607970343,99.68564049919183,UBB;MLKL;UBC;TNFSF10;CFLAR
1108,Reactome_2022,Modulation By Mtb Of Host Immune System R-HSA-9637628,3 of 7,0.00015782244672164197,0.0007959740791178465,0,0,44.14446107784431,386.442374158127,UBB;UBC;B2M
1109,Reactome_2022,Termination Of Translesion DNA Synthesis R-HSA-5656169,5 of 32,0.0001826704825500164,0.0009156076038926748,0,0,10.952699687639448,94.27894048009436,UBB;UBC;TRIM25;UBE2L6;ISG15
1110,Reactome_2022,Cell Cycle Checkpoints R-HSA-69620,14 of 271,0.0002184953405749676,0.0010884553162384,0,0,3.272867451301635,27.586168007507197,YWHAB;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1111,Reactome_2022,Intracellular Signaling By Second Messengers R-HSA-9006925,15 of 306,0.00023198815451985403,0.0011486242772568,0,0,3.1011077671767944,25.95262587049496,PSMB8;PSMB10;PML;PSMB9;BTC;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1112,Reactome_2022,Interleukin-12 Family Signaling R-HSA-447115,6 of 54,0.00028610672632715505,0.0014079918895615,0,0,7.407477341389728,60.438686511018446,GSTO1;STAT1;STAT3;HNRNPA2B1;PSME2;JAK2
1113,Reactome_2022,Intrinsic Pathway For Apoptosis R-HSA-109606,6 of 55,0.00031664415138268106,0.0015488858489321,0,0,7.255934397928356,58.46637453748536,GSDMD;CASP7;YWHAB;CASP3;STAT3;NMT1
1114,Reactome_2022,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,8 of 103,0.00035457035355058005,0.0017240187250483,0,0,5.00860662294033,39.79139507482381,UBB;RIPK2;UBC;IRF7;NLRC5;USP18;N4BP1;TLR3
1115,Reactome_2022,Regulation Of PTEN Localization R-HSA-8948747,3 of 9,0.0003693801898193211,0.0017853375841267,0,0,29.426646706586823,232.5789202688228,UBB;UBC;PML
1116,Reactome_2022,Post-translational Protein Phosphorylation R-HSA-8957275,8 of 106,0.0004305963819546196,0.0020689009594505,0,0,4.854537559704733,37.62431359835795,CSF1;GOLM1;SHISA5;NUCB1;SCG3;MIA3;APOL1;PDIA6
1117,Reactome_2022,Response Of Mtb To Phagocytosis R-HSA-9637690,4 of 22,0.0004556176681078392,0.0021762443911974,0,0,13.109776443109777,100.86473932013452,RNF213;UBB;UBC;KPNB1
1118,Reactome_2022,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,8 of 107,0.00045869528646908176,0.0021781320035841,0,0,4.805256209511529,36.93860241140864,SOCS1;BCL6;CEBPD;STAT1;STAT3;JAK2;ICAM1;MCL1
1119,Reactome_2022,Ovarian Tumor Domain Proteases R-HSA-5689896,5 of 39,0.00047427026333089566,0.0022260546463854,0,0,8.69463146704465,66.54638972066162,IFIH1;UBB;RIPK2;UBC;TRIM25
1120,Reactome_2022,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,5 of 39,0.00047427026333089566,0.0022260546463854,0,0,8.69463146704465,66.54638972066162,UBB;UBC;TRIM25;UBE2L6;ISG15
1121,Reactome_2022,Metabolism Of Amino Acids And Derivatives R-HSA-71291,16 of 364,0.0004877704957951139,0.0022762623137105,0,0,2.7664983707523185,21.096391342763503,CHGA;NNMT;SLC44A1;PPM1K;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;PSMA2;PSMB3;PSME1;PSME2;GLUL;IDO1
1122,Reactome_2022,Signaling By WNT R-HSA-195721,14 of 294,0.0004971287935677027,0.0023066776021541,0,0,3.00046439628483,22.823516775660416,PSMB8;PSMB10;PSMB9;RBX1;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1123,Reactome_2022,Growth Hormone Receptor Signaling R-HSA-982772,4 of 24,0.000644501265677102,0.0029734944757375,0,0,11.797597597597598,86.67734797535579,SOCS1;STAT1;STAT3;JAK2
1124,Reactome_2022,Interleukin-27 Signaling R-HSA-9020956,3 of 11,0.0007076019338344733,0.0031744351948817,0,0,22.067739520958085,160.0711923245111,STAT1;STAT3;JAK2
1125,Reactome_2022,Interleukin-6 Signaling R-HSA-1059683,3 of 11,0.0007076019338344733,0.0031744351948817,0,0,22.067739520958085,160.0711923245111,STAT1;STAT3;JAK2
1126,Reactome_2022,Metallothioneins Bind Metals R-HSA-5661231,3 of 11,0.0007076019338344733,0.0031744351948817,0,0,22.067739520958085,160.0711923245111,MT2A;MT1X;MT1E
1127,Reactome_2022,Regulation Of BACH1 Activity R-HSA-9708530,3 of 11,0.0007076019338344733,0.0031744351948817,0,0,22.067739520958085,160.0711923245111,UBB;UBC;RBX1
1128,Reactome_2022,"TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",3 of 11,0.0007076019338344733,0.0031744351948817,0,0,22.067739520958085,160.0711923245111,UBB;UBC;TLR3
1129,Reactome_2022,Regulation Of IFNA/IFNB Signaling R-HSA-912694,4 of 25,0.0007571521775921972,0.0033780635615651,0,0,11.235235235235235,80.73579704049152,SOCS1;STAT1;STAT2;USP18
1130,Reactome_2022,Interleukin-20 Family Signaling R-HSA-8854691,4 of 26,0.0008830306164159009,0.0038968525028788,0,0,10.723996723996724,75.41276090627198,STAT1;STAT2;STAT3;JAK2
1131,Reactome_2022,Pyroptosis R-HSA-5620971,4 of 26,0.0008830306164159009,0.0038968525028788,0,0,10.723996723996724,75.41276090627198,GSDMD;CASP3;IRF1;IRF2
1132,Reactome_2022,Butyrophilin (BTN) Family Interactions R-HSA-8851680,3 of 12,0.000931729228614326,0.0040457975060686,0,0,19.61477045908184,136.88105411013083,BTN3A1;BTN3A3;BTN3A2
1133,Reactome_2022,Interleukin-35 Signaling R-HSA-8984722,3 of 12,0.000931729228614326,0.0040457975060686,0,0,19.61477045908184,136.88105411013083,STAT1;STAT3;JAK2
1134,Reactome_2022,Maturation Of Nucleoprotein R-HSA-9683610,3 of 12,0.000931729228614326,0.0040457975060686,0,0,19.61477045908184,136.88105411013083,PARP10;PARP14;PARP9
1135,Reactome_2022,Neutrophil Degranulation R-HSA-6798695,18 of 468,0.0010538710817019,0.0045518261613935,0,0,2.409153605015674,16.515434931857406,GSDMD;DYNLT1;TMEM179B;HLA-B;HLA-C;RAB27A;HLA-A;ARPC5;GNS;CTSS;VAMP8;BST2;ERP44;PSMA2;CD47;CD68;B2M;KPNB1
1136,Reactome_2022,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,8 of 123,0.001149782017968,0.004913805255737,0,0,4.133315712964187,27.97503674600816,CD40;HLA-B;HLA-C;HLA-A;HLA-F;B2M;ICAM1;HLA-E
1137,Reactome_2022,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,8 of 123,0.001149782017968,0.004913805255737,0,0,4.133315712964187,27.97503674600816,CSF1;GOLM1;SHISA5;NUCB1;SCG3;MIA3;APOL1;PDIA6
1138,Reactome_2022,Suppression Of Phagosomal Maturation R-HSA-9637687,3 of 13,0.0011961881516228,0.0050588790579049,0,0,17.65239520958084,118.7761768139254,UBB;UBC;KPNB1
1139,Reactome_2022,p75NTR Recruits Signaling Complexes R-HSA-209543,3 of 13,0.0011961881516228,0.0050588790579049,0,0,17.65239520958084,118.7761768139254,UBB;RIPK2;UBC
1140,Reactome_2022,Cellular Responses To Stress R-HSA-2262752,24 of 722,0.0012811435279096,0.0053900960863349,0,0,2.083360033688219,13.87518244671162,HM13;STAT3;MIA3;PDIA6;PSMB10;PSMB8;PSMB9;RBX1;HELZ2;DNAJA1;MOV10;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;TXNIP;TRIM21;ATF3;FKBP5
1141,Reactome_2022,"Cell Cycle, Mitotic R-HSA-69278",19 of 523,0.0014985957265391,0.0062288190437809,0,0,2.2712700908455625,14.770584505913734,MAX;PPP2R2A;RANGAP1;PSMB10;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2;OPTN;KPNB1
1142,Reactome_2022,Regulation Of IFNG Signaling R-HSA-877312,3 of 14,0.0015035080450505,0.0062288190437809,0,0,16.046815459989112,104.30356562069318,SOCS1;STAT1;JAK2
1143,Reactome_2022,Response To Metal Ions R-HSA-5660526,3 of 14,0.0015035080450505,0.0062288190437809,0,0,16.046815459989112,104.30356562069318,MT2A;MT1X;MT1E
1144,Reactome_2022,Metabolism Of Proteins R-HSA-392499,49 of 1890,0.0015761194103887,0.0064964921890134,0,0,1.647047950992818,10.628053761062697,CSF1;UBE2L6;MIA3;IFIH1;NUB1;MUC13;TRIM25;FBXO6;B2M;PSENEN;PDIA3;RIPK2;HLA-B;SHISA5;LMO7;HLA-A;RANGAP1;PDIA6;RBX1;PSMA3;PSMA4;PPA1;PSMA2;PSME1;PSME2;SCG3;TOP1;LY6E;SP100;USP15;UBA6;USP18;PSMB10;PSMB2;UBB;PSMB3;UBC;APOL1;CHGA;GOLM1;TRAPPC4;STAT3;RAB27A;PML;PSMB8;PSMB9;CYLD;NUCB1;ITM2B
1145,Reactome_2022,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,7 of 102,0.001704246163335,0.0069891307304446,0,0,4.369250398724083,27.85236515086489,UBB;RIPK2;UBC;IRF7;NLRC5;USP18;N4BP1
1146,Reactome_2022,Cell Cycle R-HSA-1640170,22 of 654,0.001743335206753,0.0071135084818263,0,0,2.1030841872614023,13.358696570763776,MAX;YWHAB;PPP2R2A;RANGAP1;PSMB10;PSMB8;REC8;SYNE2;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2;OPTN;KPNB1
1147,Reactome_2022,SARS-CoV-1 Infection R-HSA-9678108,5 of 52,0.0017911699504909,0.0072721499989931,0,0,6.285567803127403,39.75550149092608,PARP10;UBB;UBC;PARP9;PARP14
1148,Reactome_2022,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,7 of 103,0.0018026603471222,0.0072823890639961,0,0,4.323516414141414,27.318102727074283,UBB;RIPK2;UBC;IRF7;NLRC5;USP18;N4BP1
1149,Reactome_2022,TRAF3-dependent IRF Activation Pathway R-HSA-918233,3 of 15,0.0018560564968986,0.0074609795815927,0,0,14.708832335329342,92.5082769298772,IFIH1;IRF7;TRIM25
1150,Reactome_2022,M Phase R-HSA-68886,15 of 380,0.0021037283073247,0.0084149132292991,0,0,2.462945630902748,15.181705543760838,PPP2R2A;RANGAP1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1151,Reactome_2022,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,7 of 106,0.0021245452691657,0.008456523326287,0,0,4.191857973676155,25.797521822071253,UBB;RIPK2;UBC;IRF7;NLRC5;USP18;N4BP1
1152,Reactome_2022,Amyloid Fiber Formation R-HSA-977225,6 of 79,0.0021673686633502,0.0085848944128798,0,0,4.864462194263957,29.839785598500235,PSENEN;UBB;UBC;UBE2L6;B2M;ITM2B
1153,Reactome_2022,MyD88-independent TLR4 Cascade R-HSA-166166,7 of 107,0.0022411551284755,0.0088072530822155,0,0,4.149727272727273,25.31650618957564,UBB;RIPK2;UBC;IRF7;NLRC5;USP18;N4BP1
1154,Reactome_2022,NRIF Signals Cell Death From Nucleus R-HSA-205043,3 of 16,0.0022560451245084,0.0088072530822155,0,0,13.576692768309536,82.73829285401925,PSENEN;UBB;UBC
1155,Reactome_2022,p75NTR Signals Via NF-kB R-HSA-193639,3 of 16,0.0022560451245084,0.0088072530822155,0,0,13.576692768309536,82.73829285401925,UBB;RIPK2;UBC
1156,Reactome_2022,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,8 of 140,0.0026087151433368,0.0101352951980359,0,0,3.5978631297780237,21.40331883813848,SOCS1;UBB;RIPK2;UBC;IRF7;NLRC5;USP18;N4BP1
1157,Reactome_2022,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,3 of 17,0.0027055351951788,0.0104614027546916,0,0,12.6062874251497,74.53411382750575,UBB;UBC;IRF7
1158,Reactome_2022,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,7 of 112,0.0029000809689423,0.0111434757219457,0,0,3.951111111111111,23.08640789780653,SOCS1;UBB;RIPK2;UBC;NLRC5;USP18;N4BP1
1159,Reactome_2022,Late SARS-CoV-2 Infection Events R-HSA-9772573,5 of 58,0.002909380360902,0.0111434757219457,0,0,5.572289156626506,32.541138664187415,PARP10;UBB;UBC;PARP9;PARP14
1160,Reactome_2022,Signaling By KIT In Disease R-HSA-9669938,3 of 19,0.0037605455602886,0.0142026185811831,0,0,11.02937874251497,61.57913073686957,STAT1;STAT3;JAK2
1161,Reactome_2022,Signaling By PDGFR In Disease R-HSA-9671555,3 of 19,0.0037605455602886,0.0142026185811831,0,0,11.02937874251497,61.57913073686957,STAT1;STAT3;ETV6
1162,Reactome_2022,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",3 of 19,0.0037605455602886,0.0142026185811831,0,0,11.02937874251497,61.57913073686957,UBB;UBC;TLR3
1163,Reactome_2022,Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,2 of 6,0.0040601914004794,0.0152633121166172,0,0,29.34179104477612,161.57131073034932,CASP7;CASP3
1164,Reactome_2022,Apoptotic Factor-Mediated Response R-HSA-111471,3 of 20,0.0043694849633352,0.0163503308305449,0,0,10.380063402606552,56.39602766613993,GSDMD;CASP7;CASP3
1165,Reactome_2022,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,3 of 21,0.0050347741701095,0.01875337901894,0,0,9.802894211576849,51.8709031295208,PSENEN;UBB;UBC
1166,Reactome_2022,Signaling By SCF-KIT R-HSA-1433557,4 of 42,0.0053530531640346,0.0198478500876534,0,0,6.203571993045677,32.4452286537814,SOCS1;STAT1;STAT3;JAK2
1167,Reactome_2022,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,2 of 7,0.0056211463820458,0.0205602291091048,0,0,23.47223880597015,121.6148250086244,DHX36;IRF7
1168,Reactome_2022,FLT3 Signaling By CBL Mutants R-HSA-9706377,2 of 7,0.0056211463820458,0.0205602291091048,0,0,23.47223880597015,121.6148250086244,UBB;UBC
1169,Reactome_2022,SMAC (DIABLO) Binds To IAPs R-HSA-111463,2 of 7,0.0056211463820458,0.0205602291091048,0,0,23.47223880597015,121.6148250086244,CASP7;CASP3
1170,Reactome_2022,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,6 of 96,0.0057024546732342,0.0207640950433461,0,0,3.942195367573011,20.368765850236475,UBB;RIPK2;UBC;NLRC5;USP18;N4BP1
1171,Reactome_2022,DAP12 Interactions R-HSA-2172127,4 of 43,0.0058251102902341,0.0211160248020988,0,0,6.044198044198044,31.100888529535556,HLA-B;HLA-C;B2M;HLA-E
1172,Reactome_2022,Circadian Clock R-HSA-400253,5 of 69,0.00614347850511,0.0221711313162193,0,0,4.611963478915663,23.485797552462248,HELZ2;UBB;NAMPT;UBC;CREM
1173,Reactome_2022,Interleukin-12 Signaling R-HSA-9020591,4 of 44,0.0063241044246043,0.0227220035078704,0,0,5.892792792792793,29.837489521137066,GSTO1;HNRNPA2B1;PSME2;JAK2
1174,Reactome_2022,Interleukin-10 Signaling R-HSA-6783783,4 of 45,0.0068506746544089,0.0245054970016744,0,0,5.74877316340731,28.648482988247807,CXCL10;CSF1;STAT3;ICAM1
1175,Reactome_2022,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,6 of 101,0.0072724125539245,0.0257193996204018,0,0,3.733757354110352,18.383778586867617,UBB;RIPK2;UBC;NLRC5;USP18;N4BP1
1176,Reactome_2022,Interleukin-6 Family Signaling R-HSA-6783589,3 of 24,0.0073820285528125,0.0257193996204018,0,0,8.401197604790418,41.23901586526217,STAT1;STAT3;JAK2
1177,Reactome_2022,Signaling By EGFR In Cancer R-HSA-1643713,3 of 24,0.0073820285528125,0.0257193996204018,0,0,8.401197604790418,41.23901586526217,BTC;UBB;UBC
1178,Reactome_2022,InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,2 of 8,0.0074117481664704,0.0257193996204018,0,0,19.559203980099504,95.93181158499544,UBB;UBC
1179,Reactome_2022,Myoclonic Epilepsy Of Lafora R-HSA-3785653,2 of 8,0.0074117481664704,0.0257193996204018,0,0,19.559203980099504,95.93181158499544,UBB;UBC
1180,Reactome_2022,"SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",2 of 8,0.0074117481664704,0.0257193996204018,0,0,19.559203980099504,95.93181158499544,CASP7;CASP3
1181,Reactome_2022,TRAIL Signaling R-HSA-75158,2 of 8,0.0074117481664704,0.0257193996204018,0,0,19.559203980099504,95.93181158499544,TNFSF10;CFLAR
1182,Reactome_2022,Cyclin D Associated Events In G1 R-HSA-69231,4 of 47,0.0079890109120663,0.0276045823855227,0,0,5.480829666876178,26.47069901284973,UBB;UBC;PPP2R2A;JAK2
1183,Reactome_2022,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,3 of 25,0.0082854236154993,0.028507474473667,0,0,8.018916712030485,38.436732663751606,PSENEN;UBB;UBC
1184,Reactome_2022,MHC Class II Antigen Presentation R-HSA-2132295,6 of 104,0.008352217057313,0.0286160348123974,0,0,3.618903754855416,17.317280516204846,CD74;CTSO;HLA-DRA;IFI30;CTSS;LGMN
1185,Reactome_2022,Protein Ubiquitination R-HSA-8852135,5 of 76,0.0091848499780192,0.03085554500011,0,0,4.155778041744442,19.491429730112507,UBB;UBA6;UBC;HLA-B;HLA-A
1186,Reactome_2022,Signaling By NOTCH3 R-HSA-9012852,4 of 49,0.0092448706431081,0.03085554500011,0,0,5.236703370036703,24.52707638823953,PSENEN;UBB;STAT1;UBC
1187,Reactome_2022,Calnexin/calreticulin Cycle R-HSA-901042,3 of 26,0.0092509560385627,0.03085554500011,0,0,7.669877636032283,35.918254619791554,PDIA3;UBB;UBC
1188,Reactome_2022,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,3 of 26,0.0092509560385627,0.03085554500011,0,0,7.669877636032283,35.918254619791554,CASP3;TNFSF10;CFLAR
1189,Reactome_2022,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,3 of 26,0.0092509560385627,0.03085554500011,0,0,7.669877636032283,35.918254619791554,USP15;UBB;UBC
1190,Reactome_2022,Downregulation Of ERBB4 Signaling R-HSA-1253288,2 of 9,0.0094238610345163,0.03085554500011,0,0,16.764179104477613,78.19668774835564,UBB;UBC
1191,Reactome_2022,Interleukin-23 Signaling R-HSA-9020933,2 of 9,0.0094238610345163,0.03085554500011,0,0,16.764179104477613,78.19668774835564,STAT3;JAK2
1192,Reactome_2022,Interleukin-9 Signaling R-HSA-8985947,2 of 9,0.0094238610345163,0.03085554500011,0,0,16.764179104477613,78.19668774835564,STAT1;STAT3
1193,Reactome_2022,OAS Antiviral Response R-HSA-8983711,2 of 9,0.0094238610345163,0.03085554500011,0,0,16.764179104477613,78.19668774835564,OAS1;OAS3
1194,Reactome_2022,PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,2 of 9,0.0094238610345163,0.03085554500011,0,0,16.764179104477613,78.19668774835564,UBB;UBC
1195,Reactome_2022,Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,2 of 9,0.0094238610345163,0.03085554500011,0,0,16.764179104477613,78.19668774835564,UBB;UBC
1196,Reactome_2022,FLT3 Signaling In Disease R-HSA-9682385,3 of 27,0.0102794590387168,0.0335217700379038,0,0,7.349925149700598,33.64507354098741,UBB;UBC;ETV6
1197,Reactome_2022,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,4 of 52,0.0113586670806912,0.0367880239093073,0,0,4.908658658658658,21.979865132804925,BTC;UBB;UBC;STAT3
1198,Reactome_2022,TRAF6 Mediated IRF7 Activation R-HSA-933541,3 of 28,0.011371667489207,0.0367880239093073,0,0,7.055568862275449,31.585173529343777,IFIH1;IRF7;TRIM25
1199,Reactome_2022,Nervous System Development R-HSA-9675108,17 of 545,0.0114314006952588,0.0368071600163662,0,0,1.9252781723484849,8.60867199900427,PSENEN;CD72;ARPC5;PSMB10;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;UTRN
1200,Reactome_2022,Abacavir ADME R-HSA-2161522,2 of 10,0.0116495568032095,0.0368071600163662,0,0,14.667910447761194,65.30868267360768,ABCB1;GUK1
1201,Reactome_2022,IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,2 of 10,0.0116495568032095,0.0368071600163662,0,0,14.667910447761194,65.30868267360768,UBB;UBC
1202,Reactome_2022,Interleukin-21 Signaling R-HSA-9020958,2 of 10,0.0116495568032095,0.0368071600163662,0,0,14.667910447761194,65.30868267360768,STAT1;STAT3
1203,Reactome_2022,Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,2 of 10,0.0116495568032095,0.0368071600163662,0,0,14.667910447761194,65.30868267360768,HLA-A;B2M
1204,Reactome_2022,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,2 of 10,0.0116495568032095,0.0368071600163662,0,0,14.667910447761194,65.30868267360768,CD274;STAT3
1205,Reactome_2022,Budding And Maturation Of HIV Virion R-HSA-162588,3 of 29,0.012528221850871,0.0392776685054335,0,0,6.783855366190696,29.711735928186005,UBB;UBC;CHMP5
1206,Reactome_2022,Downregulation Of ERBB2 Signaling R-HSA-8863795,3 of 29,0.012528221850871,0.0392776685054335,0,0,6.783855366190696,29.711735928186005,BTC;UBB;UBC
1207,Reactome_2022,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,3 of 30,0.0137496719792914,0.0424849958268307,0,0,6.5322687957418495,28.002139970337332,UBB;UBC;CHMP5
1208,Reactome_2022,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,3 of 30,0.0137496719792914,0.0424849958268307,0,0,6.5322687957418495,28.002139970337332,UBB;UBC;RBX1
1209,Reactome_2022,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,3 of 30,0.0137496719792914,0.0424849958268307,0,0,6.5322687957418495,28.002139970337332,UBB;UBA6;UBC
1210,Reactome_2022,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,4 of 55,0.0137605343626311,0.0424849958268307,0,0,4.619207442736855,19.79769496955935,RNF213;STAT3;LMO7;RBX1
1211,Reactome_2022,Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,2 of 11,0.0140811101799145,0.0425050612122328,0,0,13.03747927031509,55.57774525523369,UBB;UBC
1212,Reactome_2022,CASP8 Activity Is Inhibited R-HSA-5218900,2 of 11,0.0140811101799145,0.0425050612122328,0,0,13.03747927031509,55.57774525523369,TNFSF10;CFLAR
1213,Reactome_2022,Dimerization Of Procaspase-8 R-HSA-69416,2 of 11,0.0140811101799145,0.0425050612122328,0,0,13.03747927031509,55.57774525523369,TNFSF10;CFLAR
1214,Reactome_2022,Pexophagy R-HSA-9664873,2 of 11,0.0140811101799145,0.0425050612122328,0,0,13.03747927031509,55.57774525523369,UBB;UBC
1215,Reactome_2022,Signaling By Leptin R-HSA-2586552,2 of 11,0.0140811101799145,0.0425050612122328,0,0,13.03747927031509,55.57774525523369,STAT3;JAK2
1216,Reactome_2022,Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,2 of 11,0.0140811101799145,0.0425050612122328,0,0,13.03747927031509,55.57774525523369,STAT1;STAT3
1217,Reactome_2022,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,4 of 56,0.0146273085130662,0.0439902759726287,0,0,4.53014553014553,19.139253527494667,UBB;UBC;HLA-B;HLA-A
1218,Reactome_2022,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,3 of 31,0.0150364808324175,0.0447238917066779,0,0,6.298652694610778,26.43718363024856,PSENEN;UBB;UBC
1219,Reactome_2022,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,3 of 31,0.0150364808324175,0.0447238917066779,0,0,6.298652694610778,26.43718363024856,UBB;STAT1;UBC
1220,Reactome_2022,EGFR Downregulation R-HSA-182971,3 of 31,0.0150364808324175,0.0447238917066779,0,0,6.298652694610778,26.43718363024856,BTC;UBB;UBC
1221,Reactome_2022,Axon Guidance R-HSA-422475,16 of 519,0.0153668116567683,0.0455396024280872,0,0,1.8986393167474904,7.927854252022789,PSENEN;CD72;ARPC5;PSMB10;PSMB8;PSMB9;RBX1;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1222,Reactome_2022,Cytoprotection By HMOX1 R-HSA-9707564,4 of 57,0.0155278540198161,0.0456833966090244,0,0,4.444444444444445,18.511643707792764,HELZ2;HM13;STAT3;TXNIP
1223,Reactome_2022,Signaling By ERBB4 R-HSA-1236394,4 of 57,0.0155278540198161,0.0456833966090244,0,0,4.444444444444445,18.511643707792764,PSENEN;BTC;UBB;UBC
1224,Reactome_2022,Signaling By NOTCH2 R-HSA-1980145,3 of 32,0.0163890280544995,0.0480429270045258,0,0,6.081148048730126,25.000470382527965,PSENEN;UBB;UBC
1225,Reactome_2022,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,4 of 58,0.0164625576739684,0.0480848806879941,0,0,4.361917473028584,17.912941271993056,PSENEN;UBB;UBC;RBX1
1226,Reactome_2022,Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,2 of 12,0.0167109942173383,0.0484618832302812,0,0,11.73313432835821,48.00833009396599,CASP7;CASP3
1227,Reactome_2022,Josephin Domain DUBs R-HSA-5689877,2 of 12,0.0167109942173383,0.0484618832302812,0,0,11.73313432835821,48.00833009396599,UBB;UBC
1228,Reactome_2022,Transport Of Small Molecules R-HSA-382551,20 of 706,0.0169205016022219,0.0488948302526839,0,0,1.7453164230992082,7.119545855486119,ABCB1;SLC44A1;SLC43A2;ERLIN1;LSR;SLC50A1;ATP1B1;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;SLC12A7
1229,Reactome_2022,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,6 of 122,0.017348678237725,0.049954350102953,0,0,3.054536930930305,12.383822623278943,PARP10;NNMT;GSTO1;NAMPT;PARP14;PARP9
1760,GO_Biological_Process_2023,Defense Response To Virus (GO:0051607),44 of 189,1.5056386313476088e-37,2.9134107516576234e-34,0,0,20.21400494292103,1713.8733412456909,IFITM3;RTP4;CD40;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;USP18;IFI44L;IFIT3;IFIT2;IFIH1;DHX58;TRIM25;GBP2;TRIM21;RSAD2;APOBEC3G;MLKL;STAT1;STAT2;MX1;EIF2AK2;ISG15;PML;BST2;ISG20;NT5C3A;CXCL10;MOV10;PLSCR1;ZNFX1;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;SHFL;TLR3;TRIM56
1761,GO_Biological_Process_2023,Defense Response To Symbiont (GO:0140546),38 of 148,2.9348927705285234e-34,2.8395087554863463e-31,0,0,22.59087868653086,1744.2693549513542,IFITM3;RTP4;CD40;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;IFI44L;IFIT3;IFIT2;IFIH1;GBP2;RSAD2;APOBEC3G;MLKL;STAT1;STAT2;MX1;EIF2AK2;ISG15;BST2;ISG20;NT5C3A;MOV10;PLSCR1;ZNFX1;IFI27;OAS1;IRF1;OAS3;IRF2;IRF7;SHFL;TLR3;TRIM56
1762,GO_Biological_Process_2023,Negative Regulation Of Viral Process (GO:0048525),22 of 61,5.9300274018129415e-24,3.824867674169346e-21,0,0,35.14269434269434,1879.5020496770617,IFITM3;RSAD2;APOBEC3G;STAT1;MX1;IFIT5;UBP1;EIF2AK2;ISG15;IFIT1;IFIH1;BST2;ISG20;FAM111A;PLSCR1;ZNFX1;OAS1;OAS3;TRIM14;TRIM21;SHFL;N4BP1
1763,GO_Biological_Process_2023,Response To Cytokine (GO:0034097),25 of 125,5.381167494884642e-20,2.6031397756504458e-17,0,0,15.67548076923077,695.5022163330154,IFITM3;CD274;CD40;CIITA;SP100;CALCOCO2;ADAR;CXCL16;NUB1;LAMP3;CASP3;JAK2;TRIM21;MCL1;CD74;STAT1;MX1;EIF2AK2;ISG15;PML;BST2;PLSCR1;XAF1;SHFL;TRIM56
1764,GO_Biological_Process_2023,Negative Regulation Of Viral Genome Replication (GO:0045071),18 of 53,2.8823824400767745e-19,1.1154820043097114e-16,0,0,31.643887147335423,1350.8933509277178,IFITM3;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;IFIT1;IFIH1;BST2;ISG20;FAM111A;PLSCR1;ZNFX1;OAS1;OAS3;SHFL;N4BP1
1765,GO_Biological_Process_2023,Regulation Of Viral Genome Replication (GO:0045069),18 of 67,3.375287176279728e-17,1.088530114350212e-14,0,0,22.58665472458576,856.6545829811146,IFITM3;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;IFIT1;IFIH1;BST2;ISG20;FAM111A;PLSCR1;ZNFX1;OAS1;OAS3;SHFL;N4BP1
1766,GO_Biological_Process_2023,Response To Type II Interferon (GO:0034341),16 of 80,3.00847484669098e-13,8.31628404049578e-11,0,0,15.264018691588785,440.0948268893862,IFITM3;CD74;CD40;CIITA;SP100;CALCOCO2;STAT1;CXCL16;BST2;NUB1;CD47;GBP2;TRIM21;GBP1;SHFL;GBP4
1767,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),9 of 18,4.1873704170070785e-12,1.012820219613587e-09,0,0,59.920731707317074,1569.8601439758268,PDIA3;ERAP2;TAP2;TAP1;HLA-A;TAPBPL;IFI30;B2M;TAPBP
1768,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),9 of 21,2.4211791558866544e-11,5.205535185156307e-09,0,0,44.93368902439025,1098.3672430990775,ERAP2;HLA-B;TAP2;HLA-C;TAP1;HLA-DRA;HLA-A;HLA-F;HLA-E
1769,GO_Biological_Process_2023,Negative Regulation Of Innate Immune Response (GO:0045824),12 of 52,4.860403864522699e-11,9.404881477851424e-09,0,0,18.11353846153846,430.1478943507418,USP15;OAS1;OAS3;STAT2;DHX58;NLRC5;TRAFD1;SERPING1;ISG15;SAMHD1;TRIM21;USP18
1770,GO_Biological_Process_2023,Antiviral Innate Immune Response (GO:0140374),11 of 46,2.082236897552848e-10,3.6628439970588736e-08,0,0,18.922699386503066,421.83253864006224,IFIH1;CXCL10;OAS1;DHX58;MX1;TRIM25;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2
1771,GO_Biological_Process_2023,Positive Regulation Of Type I Interferon Production (GO:0032481),12 of 64,6.45393173059072e-10,1.0406964915577537e-07,0,0,13.924970414201184,294.6685466230276,IFIH1;OAS1;RIPK2;STAT1;IRF1;OAS3;DHX58;DHX36;IRF7;ISG15;TLR3;TRIM56
1772,GO_Biological_Process_2023,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),18 of 175,1.041049312674536e-09,1.5495618615578668e-07,0,0,7.010522532595891,144.99889467328177,CD74;CD40;RIPK2;IFIT5;SHISA5;SECTM1;CFLAR;BST2;DHX36;MIER1;TNFSF10;S100A13;TRIM25;RBCK1;TRIM38;TRIM21;TRIM22;APOL2
1773,GO_Biological_Process_2023,Response To Type I Interferon (GO:0034340),6 of 9,1.7622511651577091e-09,2.435682860414405e-07,0,0,118.79154078549848,2394.442334735823,SP100;MX1;ISG15;IFIT1;SHFL;TRIM56
1774,GO_Biological_Process_2023,Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),7 of 15,2.076687607782949e-09,2.678927014040004e-07,0,0,52.11553030303031,1041.919307486247,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18
1775,GO_Biological_Process_2023,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),20 of 232,2.758675481901409e-09,3.3362731609245164e-07,0,0,5.788643533123029,114.08556888782311,CD74;CD40;RIPK2;STAT1;IFIT5;SHISA5;SECTM1;CFLAR;BST2;DHX36;MIER1;TNFSF10;S100A13;TRIM25;RBCK1;TRIM38;TRIM21;TRIM22;OPTN;APOL2
1776,GO_Biological_Process_2023,Positive Regulation Of Interferon-Beta Production (GO:0032728),9 of 36,6.207424460309222e-09,7.065509606293144e-07,0,0,19.95528455284553,377.1053843078895,IFIH1;OAS1;RIPK2;IRF1;OAS3;IRF7;ISG15;TLR3;TRIM56
1777,GO_Biological_Process_2023,Regulation Of Innate Immune Response (GO:0045088),12 of 78,6.9108974235962156e-09,7.429214730365932e-07,0,0,10.963356643356644,206.00329491235885,AKIRIN2;PLSCR1;IRF1;DHX58;TRAFD1;IFI35;PARP9;SAMHD1;TRIM21;N4BP1;HLA-E;TRIM56
1778,GO_Biological_Process_2023,Defense Response To Bacterium (GO:0042742),18 of 204,1.2073539493948504e-08,1.2295946800415978e-06,0,0,5.9086864192537165,107.72864558981432,GSDMD;CHGA;AKIRIN2;ISG15;HLA-A;HLA-E;RNF213;ZNFX1;OAS1;OAS3;TNFRSF14;RBCK1;GBP2;GBP1;OPTN;TLR3;GBP4;GBP3
1779,GO_Biological_Process_2023,Response To Interferon-Beta (GO:0035456),8 of 29,1.8856400345955945e-08,1.8243567334712372e-06,0,0,22.74366767983789,404.528276490646,IFITM3;BST2;PLSCR1;OAS1;STAT1;IRF1;XAF1;SHFL
1780,GO_Biological_Process_2023,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),8 of 33,5.7517120605974e-08,5.299791827264748e-06,0,0,19.100790273556232,318.43277360566043,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18;TRIM56
1781,GO_Biological_Process_2023,Positive Regulation Of Cytokine Production (GO:0001819),21 of 320,1.30790424250613e-07,1.129458386797032e-05,0,0,4.303839803564625,68.21443893955997,CD74;CD274;AKIRIN2;CD40;BTN3A1;RIPK2;STAT3;EIF2AK2;ISG15;HLA-A;BTN3A2;HLA-E;IFIH1;MDK;IRF1;DHX58;S100A13;IRF7;TNFRSF14;JAK2;TLR3
1782,GO_Biological_Process_2023,Regulation Of Interferon-Beta Production (GO:0032648),9 of 50,1.3425086768130094e-07,1.129458386797032e-05,0,0,13.131915526472335,207.79359599820572,IFIH1;OAS1;RIPK2;IRF1;OAS3;IRF7;ISG15;TLR3;TRIM56
1783,GO_Biological_Process_2023,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),9 of 59,5.893628635902484e-07,4.751738087696378e-05,0,0,10.763231707317074,154.39020416022217,CYLD;OAS1;OAS3;STAT2;NLRC5;ISG15;SAMHD1;PARP14;USP18
1784,GO_Biological_Process_2023,Regulation Of Viral Entry Into Host Cell (GO:0046596),8 of 44,6.248172261690074e-07,4.822608818002892e-05,0,0,13.257007767646066,189.38704996619728,IFITM3;CD74;CIITA;TRIM25;TRIM38;TRIM21;TRIM22;LY6E
1785,GO_Biological_Process_2023,Regulation Of Immune Response (GO:0050776),10 of 77,6.514519295669913e-07,4.822608818002892e-05,0,0,8.94426947829659,127.40273102699652,PLSCR1;RSAD2;BCL6;IRF1;SPPL2A;DHX58;IRF7;HLA-DRA;SAMHD1;N4BP1
1786,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),7 of 31,6.729221606515663e-07,4.822608818002892e-05,0,0,17.35770202020202,246.6813459320012,HLA-DRA;HLA-A;IFI30;HLA-F;CTSS;HLA-E;LGMN
1787,GO_Biological_Process_2023,Positive Regulation Of Interferon-Alpha Production (GO:0032727),6 of 21,9.594640623644444e-07,6.40269482394165e-05,0,0,23.74380664652568,329.01534007381275,IFIH1;RIPK2;STAT1;DHX36;IRF7;TLR3
1788,GO_Biological_Process_2023,Regulation Of Cytokine Production (GO:0001817),14 of 167,9.595770020377668e-07,6.40269482394165e-05,0,0,5.527024019101964,76.5867187041622,BTN3A1;HLA-B;EIF2AK2;ISG15;BTN3A3;BTN3A2;IFIH1;BCL6;S100A13;IRF7;CD47;TRIM21;N4BP1;TRIM56
1789,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I (GO:0019885),4 of 6,1.1565819793642348e-06,7.459953766899314e-05,0,0,118.08408408408408,1614.2143266175324,ERAP2;TAP2;TAP1;HLA-A
1790,GO_Biological_Process_2023,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),21 of 367,1.2393242370638446e-06,7.735781931350126e-05,0,0,3.710186946659837,50.4620459930041,DTX3L;UBA6;RNF19B;UBE2L6;PML;RBX1;HERC5;NUB1;SH3BGRL;PSMA3;RNF114;RNF213;PSMA4;IFI27;PSMB2;PSMA2;PSMB3;TRIM25;RBCK1;HERC6;CHMP5
1791,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),5 of 13,1.518673624906885e-06,8.396095611985206e-05,0,0,37.00112951807229,495.72904202624807,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
1792,GO_Biological_Process_2023,"Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486)",5 of 13,1.518673624906885e-06,8.396095611985206e-05,0,0,37.00112951807229,495.72904202624807,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
1793,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),5 of 13,1.518673624906885e-06,8.396095611985206e-05,0,0,37.00112951807229,495.72904202624807,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
1794,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),5 of 13,1.518673624906885e-06,8.396095611985206e-05,0,0,37.00112951807229,495.72904202624807,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
1795,GO_Biological_Process_2023,Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),6 of 23,1.7348060930407678e-06,9.324582750094128e-05,0,0,20.94828505420295,277.87093432646475,IFIH1;CYLD;OAS3;DHX58;IRF7;TRIM25
1796,GO_Biological_Process_2023,Defense Response To Protozoan (GO:0042832),5 of 15,3.446519369426909e-06,0.0001802436481038127,0,0,29.59789156626506,372.2865929656603,BATF2;CD40;GBP2;GBP1;GBP4
1797,GO_Biological_Process_2023,Regulation Of Interferon-Alpha Production (GO:0032647),6 of 26,3.7913356432453374e-06,0.00019305880183367709,0,0,17.80332326283988,222.23518455448365,IFIH1;RIPK2;STAT1;DHX36;IRF7;TLR3
1798,GO_Biological_Process_2023,Protein Ubiquitination (GO:0016567),22 of 434,4.996495887157469e-06,0.0002479030651705052,0,0,3.2633841886269077,39.83539233172758,DTX3L;UBA6;MYCBP2;RNF19B;UBE2L6;LMO7;ISG15;RBX1;HERC5;NUB1;RNF114;RNF213;UBB;TRIM14;TRIM69;TRIM25;RBCK1;TRIM38;TRIM21;TRIM22;HERC6;TRIM56
1799,GO_Biological_Process_2023,Regulation Of Type I Interferon Production (GO:0032479),8 of 59,6.276409230790493e-06,0.0003036212965394901,0,0,9.350736039096487,112.0097788585175,CYLD;IRF1;DHX58;IRF7;XAF1;TRIM21;RBX1;TRIM56
1800,GO_Biological_Process_2023,Type II Interferon-Mediated Signaling Pathway (GO:0060333),4 of 9,9.332961513270396e-06,0.0004404702567848346,0,0,47.22642642642643,546.9744956309985,SP100;STAT1;IRF1;JAK2
1801,GO_Biological_Process_2023,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),24 of 525,1.0646735002708925e-05,0.0004905102911962326,0,0,2.932716037573416,33.58035317502149,CD74;CD40;RIPK2;IFIT5;SHISA5;SECTM1;EIF2AK2;IFI35;CFLAR;BST2;GRM4;DHX36;MIER1;S100A13;TNFSF10;TRIM25;RBCK1;TRIM38;JAK2;TRIM21;TLR3;TRIM22;APOL2;TRIM56
1802,GO_Biological_Process_2023,Cellular Response To Type II Interferon (GO:0071346),8 of 66,1.4676275954486983e-05,0.0006604324179519144,0,0,8.219264228068337,91.47447859240252,SP100;STAT1;IRF1;CD47;JAK2;GBP2;GBP1;GBP4
1803,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),6 of 33,1.6513078957052792e-05,0.0007262001768612989,0,0,13.182947297750925,145.16214990983588,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
1804,GO_Biological_Process_2023,Interferon-Mediated Signaling Pathway (GO:0140888),7 of 49,1.6947557453089104e-05,0.0007287449704828315,0,0,9.90959595959596,108.8607450203235,IFITM3;SP100;IFI27;STAT1;IRF1;STAT2;JAK2
1805,GO_Biological_Process_2023,Modification-Dependent Protein Catabolic Process (GO:0019941),13 of 192,2.3949154100965184e-05,0.0010074263735949,0,0,4.367404648596455,46.46734046890611,DTX3L;UBA6;RNF19B;UBE2L6;ISG15;RBX1;HERC5;NUB1;RNF114;RNF213;UBB;TRIM25;HERC6
1806,GO_Biological_Process_2023,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),6 of 36,2.7830629030644805e-05,0.001145792918602,0,0,11.86283987915408,124.43375684045064,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
1807,GO_Biological_Process_2023,Protein Polyubiquitination (GO:0000209),14 of 226,3.158557832561619e-05,0.0012732936262514,0,0,3.976780185758514,41.21061717313778,DTX3L;MYCBP2;RNF19B;UBE2L6;RBX1;RNF114;RNF213;IFI27;TRIM25;RBCK1;TRIM38;TRIM21;TRIM22;TRIM56
1808,GO_Biological_Process_2023,Regulation Of Defense Response (GO:0031347),9 of 97,3.826550575052979e-05,0.001483877774632,0,0,6.10362389135255,62.07972483464901,HERC5;CYLD;BCL6;IRF1;DHX58;JAK2;SAMHD1;USP18;N4BP1
1809,GO_Biological_Process_2023,Cellular Response To Type I Interferon (GO:0071357),6 of 38,3.834309495173157e-05,0.001483877774632,0,0,11.120279456193352,113.0814112016424,IFITM3;SP100;IFI27;STAT1;STAT2;IFIT1
1810,GO_Biological_Process_2023,Regulation Of Viral Life Cycle (GO:1903900),5 of 24,4.306130741223094e-05,0.0016337966635817,0,0,15.570703868103996,156.53050631563082,LAMP3;TRIM25;TRIM38;TRIM21;TRIM22
1811,GO_Biological_Process_2023,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),6 of 39,4.467717402543663e-05,0.0016625063796003,0,0,10.782751991211205,108.0005597365945,USP15;RSAD2;DHX58;IFI35;DDX60;TLR3
1812,GO_Biological_Process_2023,Interleukin-27-Mediated Signaling Pathway (GO:0070106),3 of 5,4.624058027231438e-05,0.0016882174118288,0,0,88.29790419161677,881.3590212430455,OAS1;STAT1;MX1
1813,GO_Biological_Process_2023,Negative Regulation Of Viral Transcription (GO:0032897),4 of 13,5.020455109935013e-05,0.0017989964143933,0,0,26.231564898231564,259.6768814593538,IFITM3;UBP1;TRIM14;TRIM21
1814,GO_Biological_Process_2023,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),11 of 152,5.529289144211381e-05,0.0019453044534634,0,0,4.671757385893922,45.79661258702505,CD40;RIPK2;STAT3;TRIM25;TRIM14;EIF2AK2;RBCK1;CFLAR;TRIM38;TRIM21;TRIM22
1815,GO_Biological_Process_2023,Regulation Of Response To External Stimulus (GO:0032101),10 of 127,5.910142407090021e-05,0.0020421652781641,0,0,5.108863274000889,49.74119834380483,HERC5;CYLD;BCL6;IRF1;DHX58;NMT1;JAK2;SAMHD1;USP18;N4BP1
1816,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),6 of 43,7.888695088034146e-05,0.0026780043851484,0,0,9.615089409651343,90.83850654416337,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
1817,GO_Biological_Process_2023,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),6 of 44,9.005979592510704e-05,0.0030045811226738,0,0,9.361583717602162,87.20349598460443,CD74;CSF1;NLRC5;PARP14;PARP9;TRIM56
1818,GO_Biological_Process_2023,Positive Regulation Of Defense Response To Virus By Host (GO:0002230),5 of 28,9.4211893424821e-05,0.0030898307419835,0,0,12.86013619696176,119.21300121658764,APOBEC3G;DTX3L;STAT1;PARP9;TRIM22
1819,GO_Biological_Process_2023,Positive Regulation Of Innate Immune Response (GO:0045089),6 of 45,0.00010245599255942004,0.0033042057600412,0,0,9.12107831745294,83.78692950262055,AKIRIN2;PLSCR1;NLRC5;IFI35;HLA-E;TRIM56
1820,GO_Biological_Process_2023,Regulation Of Type II Interferon Production (GO:0032649),8 of 87,0.0001099415270258352,0.0034874894228687,0,0,6.027932745950522,54.947994110910585,CD274;BTN3A1;ISG15;BTN3A2;HLA-A;CD47;JAK2;TLR3
1821,GO_Biological_Process_2023,Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),4 of 16,0.0001227807707276602,0.00383194824771,0,0,19.67067067067067,177.13655600908402,HLA-B;HLA-A;HLA-F;HLA-E
1822,GO_Biological_Process_2023,Post-Translational Protein Modification (GO:0043687),6 of 48,0.00014795425878043233,0.0045235418502451,0,0,8.468277945619336,74.67841850792253,PARP10;PARP3;JAK2;PARP9;PARP12;RBX1
1823,GO_Biological_Process_2023,Regulation Of Response To Biotic Stimulus (GO:0002831),5 of 31,0.00015626929108657547,0.0045235418502451,0,0,11.374536607970343,99.68564049919183,HERC5;IRF1;DHX58;SAMHD1;N4BP1
1824,GO_Biological_Process_2023,NAD Biosynthetic Process (GO:0009435),4 of 17,0.00015843434386562518,0.0045235418502451,0,0,18.15661815661816,158.87350066562772,PARP10;NNMT;NAMPT;PARP9
1825,GO_Biological_Process_2023,Regulation Of Viral Transcription (GO:0046782),4 of 17,0.00015843434386562518,0.0045235418502451,0,0,18.15661815661816,158.87350066562772,IFITM3;UBP1;TRIM14;TRIM21
1826,GO_Biological_Process_2023,Response To Interferon-Alpha (GO:0035455),4 of 17,0.00015843434386562518,0.0045235418502451,0,0,18.15661815661816,158.87350066562772,IFITM3;BST2;LAMP3;EIF2AK2
1827,GO_Biological_Process_2023,Regulation Of Endopeptidase Activity (GO:0052548),7 of 69,0.00015961897783281452,0.0045235418502451,0,0,6.7061094819159335,58.62964400331811,PSENEN;PSMA3;PSME1;PSME2;SERPING1;PSMB8;PSMB9
1828,GO_Biological_Process_2023,Protein Modification By Small Protein Conjugation (GO:0032446),17 of 364,0.0001613045931095177,0.0045235418502451,0,0,2.9572406340057635,25.823264268943216,UBA6;MYCBP2;UBE2L6;LMO7;ISG15;RANGAP1;PML;RBX1;HERC5;IFIH1;NUB1;RNF213;UBB;TRIM14;TRIM69;TRIM21;HERC6
1829,GO_Biological_Process_2023,Regulation Of Interleukin-12 Production (GO:0032655),6 of 50,0.0001862540473579595,0.005148594023395,0,0,8.082532271354024,69.41601183557964,CD40;MDK;RIPK2;HLA-B;CD47;TLR3
1830,GO_Biological_Process_2023,Peptide Antigen Assembly With MHC Protein Complex (GO:0002501),4 of 18,0.0002010065912147848,0.0054781373802902,0,0,16.85885885885886,143.50552080078606,PDIA3;HLA-DRA;TAPBPL;TAPBP
1831,GO_Biological_Process_2023,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),6 of 51,0.00020812908509899928,0.0055934691620356,0,0,7.902517623363545,66.99242412724999,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
1832,GO_Biological_Process_2023,Cellular Response To Cytokine Stimulus (GO:0071345),15 of 308,0.00024877822012305136,0.006520526960455,0,0,3.0796218175651324,25.55762360449704,CD40;STAT1;STAT3;MT1X;IFIT1;MT2A;SOCS1;OAS1;IRF1;CD47;JAK2;GBP2;GBP1;GBP4;GBP3
1833,GO_Biological_Process_2023,Protein poly-ADP-ribosylation (GO:0070212),3 of 8,0.0002493638217434992,0.006520526960455,0,0,35.31377245508982,292.9841596711931,PARP10;PARP3;PARP9
1834,GO_Biological_Process_2023,Positive Regulation Of Defense Response (GO:0031349),9 of 124,0.00025556500537361905,0.0065935771386393,0,0,4.664156945917285,38.58206370232551,GSDMD;AKIRIN2;PLSCR1;MDK;IFI35;CD47;OPTN;TLR3;TRIM56
1835,GO_Biological_Process_2023,Negative Regulation Of Viral Life Cycle (GO:1903901),4 of 20,0.0003099024587329989,0.0078902797058993,0,0,14.75,119.16898114887752,IFITM3;BST2;CIITA;LY6E
1836,GO_Biological_Process_2023,Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),7 of 78,0.00034352303595142026,0.0086114538228962,0,0,5.853350405463082,46.68782355166123,IFIH1;OAS1;OAS3;STAT3;JAK2;TLR3;HLA-E
1837,GO_Biological_Process_2023,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),15 of 319,0.00036116185368345567,0.0086114538228962,0,0,2.9665025335076822,23.51304596112576,AKIRIN2;ERLIN1;PML;RBX1;PSMA3;SH3BGRL;PSMA4;IFI27;PSMB2;PSMA2;PSMB3;TRIM25;FBXO6;RBCK1;UBXN4
1838,GO_Biological_Process_2023,Regulation Of Defense Response To Virus By Host (GO:0050691),5 of 37,0.0003690817751874242,0.0086114538228962,0,0,9.23898719879518,73.02950340828981,APOBEC3G;DTX3L;STAT1;PARP9;TRIM22
1839,GO_Biological_Process_2023,Type I Interferon-Mediated Signaling Pathway (GO:0060337),5 of 37,0.0003690817751874242,0.0086114538228962,0,0,9.23898719879518,73.02950340828981,IFITM3;SP100;IFI27;STAT1;STAT2
1840,GO_Biological_Process_2023,NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),3 of 9,0.0003693801898193211,0.0086114538228962,0,0,29.426646706586823,232.5789202688228,PARP10;NNMT;PARP9
1841,GO_Biological_Process_2023,Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),3 of 9,0.0003693801898193211,0.0086114538228962,0,0,29.426646706586823,232.5789202688228,USP15;DHX58;DDX60
1842,GO_Biological_Process_2023,"Regulation Of CD8-positive, Alpha-Beta T Cell Activation (GO:2001185)",3 of 9,0.0003693801898193211,0.0086114538228962,0,0,29.426646706586823,232.5789202688228,IRF1;HLA-A;HLA-E
1843,GO_Biological_Process_2023,Modulation By Symbiont Of Entry Into Host (GO:0052372),4 of 21,0.00037776463846787866,0.0087020782789922,0,0,13.881646352234588,109.40457547266077,TRIM25;TRIM38;TRIM21;TRIM22
1844,GO_Biological_Process_2023,Positive Regulation Of Immune Response (GO:0050778),7 of 80,0.0004013978429675062,0.0091377038369661,0,0,5.692403486924035,44.51776875644511,AKIRIN2;CD74;PLSCR1;RSAD2;HLA-DRA;IFI35;TRIM56
1845,GO_Biological_Process_2023,Regulation Of Protein Export From Nucleus (GO:0046825),4 of 22,0.0004556176681078392,0.0101335653768812,0,0,13.109776443109777,100.86473932013452,SP100;IFI27;RANGAP1;UHMK1
1846,GO_Biological_Process_2023,Regulation Of Regulatory T Cell Differentiation (GO:0045589),4 of 22,0.0004556176681078392,0.0101335653768812,0,0,13.109776443109777,100.86473932013452,SOCS1;BCL6;MDK;IRF1
1847,GO_Biological_Process_2023,Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),7 of 82,0.00046681459198348574,0.0102646163123641,0,0,5.540040404040404,42.48977420928938,IFIH1;OAS1;OAS3;STAT3;JAK2;TLR3;HLA-E
1848,GO_Biological_Process_2023,Response To Tumor Necrosis Factor (GO:0034612),8 of 108,0.00048826388305964696,0.0106156248732631,0,0,4.756960486322188,36.27018043659397,NUB1;CD40;CASP3;JAK2;GBP2;GBP1;CXCL16;GBP3
1849,GO_Biological_Process_2023,Apoptotic Process (GO:0006915),12 of 228,0.0005153796046997171,0.0109602862437337,0,0,3.324273504273504,25.166767703948167,PLSCR1;CASP7;IFI27;RIPK2;CASP3;IRF1;MX1;IFI6;FAS;CFLAR;JAK2;IFIT2
1850,GO_Biological_Process_2023,Positive Regulation Of MHC Class II Biosynthetic Process (GO:0045348),3 of 10,0.0005211092167563334,0.0109602862437337,0,0,25.221556886227543,190.6636432879255,CIITA;RFX5;JAK2
1851,GO_Biological_Process_2023,Protein auto-ADP-ribosylation (GO:0070213),3 of 10,0.0005211092167563334,0.0109602862437337,0,0,25.221556886227543,190.6636432879255,PARP10;PARP3;PARP12
1852,GO_Biological_Process_2023,Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),4 of 23,0.0005442608038459694,0.0113241360800209,0,0,12.419155998103369,93.34339494143704,STAT3;BTN3A3;BTN3A2;IL18BP
1853,GO_Biological_Process_2023,Defense Response To Gram-positive Bacterium (GO:0050830),7 of 85,0.0005806019595103709,0.0119517531026868,0,0,5.326146076146076,39.687485248248585,CHGA;GSDMD;TNFRSF14;HLA-A;GBP2;GBP4;HLA-E
1854,GO_Biological_Process_2023,Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),4 of 24,0.000644501265677102,0.0131274731482651,0,0,11.797597597597598,86.67734797535579,NUB1;UBB;PSME1;PSME2
1855,GO_Biological_Process_2023,Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),3 of 11,0.0007076019338344733,0.0142626014788511,0,0,22.067739520958085,160.0711923245111,NLRC5;PARP14;PARP9
1856,GO_Biological_Process_2023,Cellular Response To Virus (GO:0098586),6 of 64,0.0007214676524526577,0.014392163994803,0,0,6.127200750078133,44.32553668068217,IFIH1;EIF5A;CXCL10;OAS1;IFI6;JAK2
1857,GO_Biological_Process_2023,Positive Regulation Of Peptidase Activity (GO:0010952),4 of 25,0.0007571521775921972,0.0149498924861316,0,0,11.235235235235235,80.73579704049152,PSENEN;PSME1;PSME2;CTSS
1858,GO_Biological_Process_2023,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),8 of 117,0.0008302989883606131,0.0162285711361392,0,0,4.362176180251526,30.944076894224104,CD274;CXCL10;CXCL9;CASP7;GBP2;CD68;CHMP5;GBP3
1859,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),4 of 26,0.0008830306164159009,0.0170866424276476,0,0,10.723996723996724,75.41276090627198,HLA-DRA;IFI30;CTSS;LGMN
1860,GO_Biological_Process_2023,Positive Regulation Of Cellular Extravasation (GO:0002693),3 of 12,0.000931729228614326,0.0178504560135516,0,0,19.61477045908184,136.88105411013083,MDK;CD47;ICAM1
1861,GO_Biological_Process_2023,Positive Regulation Of Programmed Cell Death (GO:0043068),12 of 245,0.0009683472758319876,0.0183701174385774,0,0,3.079035985473754,21.36826273584352,DNAJA1;BCL6;CASP3;TNFSF10;FAS;CFLAR;GBP2;GBP1;IFIT2;GADD45G;MCL1;GBP3
1862,GO_Biological_Process_2023,Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),4 of 27,0.0010229557638526,0.0192176641073286,0,0,10.257213735474606,70.62152209862049,VMP1;GSTO1;CALM3;ATP1B1
1863,GO_Biological_Process_2023,T Cell Receptor Signaling Pathway (GO:0050852),7 of 95,0.0011267792318198,0.0209645943612635,0,0,4.718491735537191,32.030971328981735,BTN3A1;THEMIS2;RIPK2;BTN3A3;BTN3A2;HLA-A;RBCK1
1864,GO_Biological_Process_2023,Protein K48-linked Ubiquitination (GO:0070936),6 of 70,0.0011597472372212,0.0212350832421121,0,0,5.551076283987915,37.5227954397485,DTX3L;IFI27;MYCBP2;TRIM25;TRIM21;RBX1
1865,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),4 of 28,0.0011777471594625,0.0212350832421121,0,0,9.82932932932933,66.29048960248615,HLA-DRA;IFI30;CTSS;LGMN
1866,GO_Biological_Process_2023,Pyroptosis (GO:0070269),4 of 28,0.0011777471594625,0.0212350832421121,0,0,9.82932932932933,66.29048960248615,GSDMD;IFI27;CASP3;TRIM21
1867,GO_Biological_Process_2023,Membrane Protein Intracellular Domain Proteolysis (GO:0031293),3 of 13,0.0011961881516228,0.0212350832421121,0,0,17.65239520958084,118.7761768139254,PSENEN;HM13;SPPL2A
1868,GO_Biological_Process_2023,Regulation Of ERBB Signaling Pathway (GO:1901184),3 of 13,0.0011961881516228,0.0212350832421121,0,0,17.65239520958084,118.7761768139254,RHBDF2;IFI6;LGMN
1869,GO_Biological_Process_2023,Cellular Response To Lipopolysaccharide (GO:0071222),8 of 124,0.0012114523667393,0.0213105484512788,0,0,4.097474059322922,27.518370823640836,CD274;CXCL10;CXCL9;CASP7;GBP2;CD68;CHMP5;GBP3
1870,GO_Biological_Process_2023,Positive Regulation Of Response To External Stimulus (GO:0032103),9 of 155,0.0012858891561562,0.0224161758302916,0,0,3.667996157701303,24.4153006128435,GSDMD;AKIRIN2;PLSCR1;MDK;IFI35;CD47;OPTN;TLR3;TRIM56
1871,GO_Biological_Process_2023,Proteasomal Protein Catabolic Process (GO:0010498),11 of 220,0.0013223162790049,0.0228453749988801,0,0,3.140781401356151,20.81826223287554,PSMA3;SH3BGRL;PSMA4;IFI27;PSMB2;PSMA2;PSMB3;RBCK1;TRIM21;PML;RBX1
1872,GO_Biological_Process_2023,Positive Regulation Of Endopeptidase Activity (GO:0010950),4 of 29,0.001348223050486,0.0230868283423942,0,0,9.435675675675675,62.36007682935849,PSENEN;STAT3;PSME1;PSME2
1873,GO_Biological_Process_2023,Regulation Of Tumor Necrosis Factor Production (GO:0032680),8 of 127,0.0014124241687648,0.0239740418119305,0,0,3.9935633827999286,26.207551164590324,IFIH1;OAS1;OAS3;STAT3;CD47;JAK2;TLR3;HLA-E
1874,GO_Biological_Process_2023,Regulation Of MHC Class II Biosynthetic Process (GO:0045346),3 of 14,0.0015035080450505,0.0252981571058511,0,0,16.046815459989112,104.30356562069318,CIITA;RFX5;JAK2
1875,GO_Biological_Process_2023,Response To Lipopolysaccharide (GO:0032496),9 of 159,0.0015350009291812,0.0256054034307386,0,0,3.569451219512195,23.12727505276182,CD274;CXCL10;CXCL9;CASP7;JAK2;GBP2;CD68;CHMP5;GBP3
1876,GO_Biological_Process_2023,Positive Regulation Of Leukocyte Migration (GO:0002687),4 of 31,0.0017394855864269,0.0285246153367471,0,0,8.73584695806918,55.50902040698767,CSF1;MDK;MIA3;ICAM1
1877,GO_Biological_Process_2023,Receptor Signaling Pathway Via STAT (GO:0097696),4 of 31,0.0017394855864269,0.0285246153367471,0,0,8.73584695806918,55.50902040698767,STAT1;STAT2;STAT3;JAK2
1878,GO_Biological_Process_2023,Alpha-Beta T Cell Activation (GO:0046631),3 of 15,0.0018560564968986,0.0296815646404874,0,0,14.708832335329342,92.5082769298772,RSAD2;HLA-A;HLA-E
1879,GO_Biological_Process_2023,Regulation Of Monocyte Differentiation (GO:0045655),3 of 15,0.0018560564968986,0.0296815646404874,0,0,14.708832335329342,92.5082769298772,CD74;CSF1;IRF7
1880,GO_Biological_Process_2023,Cellular Response To Zinc Ion (GO:0071294),3 of 15,0.0018560564968986,0.0296815646404874,0,0,14.708832335329342,92.5082769298772,MT2A;MT1X;MT1E
1881,GO_Biological_Process_2023,Positive Regulation Of Inflammatory Response (GO:0050729),7 of 104,0.0019054288322196,0.0302213507405322,0,0,4.278725398313028,26.79786334840393,GSDMD;VAMP8;MDK;C2CD4A;IFI35;CD47;TLR3
1882,GO_Biological_Process_2023,Positive Regulation Of Chemokine Production (GO:0032722),5 of 53,0.0019508831267774,0.0306907223602797,0,0,6.154304718875502,38.3996188866453,CD74;OAS1;OAS3;EIF2AK2;TLR3
1883,GO_Biological_Process_2023,Proteolysis Involved In Protein Catabolic Process (GO:0051603),6 of 78,0.0020309776742878,0.0316930790302181,0,0,4.932275931520644,30.57635232650396,UBB;HM13;ISG15;TRIM21;CTSS;LGMN
1884,GO_Biological_Process_2023,Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),4 of 33,0.002203206513188,0.033568540181251,0,0,8.132546339442891,49.75362928267175,TNFRSF14;HLA-A;HLA-F;HLA-E
1885,GO_Biological_Process_2023,Positive Regulation Of Interleukin-12 Production (GO:0032735),4 of 33,0.002203206513188,0.033568540181251,0,0,8.132546339442891,49.75362928267175,CD40;MDK;RIPK2;TLR3
1886,GO_Biological_Process_2023,Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),4 of 33,0.002203206513188,0.033568540181251,0,0,8.132546339442891,49.75362928267175,CXCL10;CXCL9;GSTO1;CALM3
1887,GO_Biological_Process_2023,Positive Regulation Of T Cell Activation (GO:0050870),7 of 107,0.0022411551284755,0.0338799622937513,0,0,4.149727272727273,25.31650618957564,CD274;MDK;HLA-DRA;HLA-A;CD47;JAK2;B2M
1888,GO_Biological_Process_2023,Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),6 of 81,0.0024607512369917,0.0365377043465905,0,0,4.734259818731118,28.44006501372322,PARP10;CYLD;TAX1BP1;NLRC5;RBCK1;TRIM21
1889,GO_Biological_Process_2023,DNA Damage Checkpoint Signaling (GO:0000077),4 of 34,0.0024642292215107,0.0365377043465905,0,0,7.861061061061061,47.21255960748123,DTX3L;FBXO6;NBN;PARP9
1890,GO_Biological_Process_2023,Cellular Response To Peptide (GO:1901653),5 of 56,0.0024924945600774,0.0365377043465905,0,0,5.791400897708481,34.716386112789145,RIPK2;ICAM1;CHMP5;SNX6;LGMN
1891,GO_Biological_Process_2023,Pattern Recognition Receptor Signaling Pathway (GO:0002221),5 of 56,0.0024924945600774,0.0365377043465905,0,0,5.791400897708481,34.716386112789145,IFIH1;DHX58;TRIM25;CTSS;TLR3
1892,GO_Biological_Process_2023,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),28 of 938,0.0025436064091818,0.0370066045245626,0,0,1.867363704256908,11.155952625883028,CD40;CIITA;MAX;NLRC5;UBP1;ASCL2;HELZ2;EPCAM;DHX36;NAMPT;EIF5A;AKIRIN2;PCGF5;RIPK2;STAT1;STAT2;STAT3;LMO7;CXCL10;PLSCR1;IRF1;RFX5;IRF2;IRF7;PTMA;ATF3;TLR3;IRF9
1893,GO_Biological_Process_2023,Regulation Of Inflammatory Response (GO:0050727),11 of 240,0.0026189518207144,0.0378184460677795,0,0,2.8635304203391647,17.023634255931714,GSDMD;CYLD;BCL6;MDK;STAT3;IFI35;CD47;JAK2;USP18;TLR3;SNX6
1894,GO_Biological_Process_2023,Protein Transport (GO:0015031),13 of 313,0.0026466705869573,0.0378324456341608,0,0,2.589701646090535,15.368462213744282,GSDMD;MACF1;CD74;UNC93B1;MIA3;AP3B1;DNAJC15;VMP1;ARL5B;TXNIP;VAMP5;OPTN;SNX6
1895,GO_Biological_Process_2023,Positive Regulation Of Alpha-Beta T Cell Proliferation (GO:0046641),3 of 17,0.0027055351951788,0.0378324456341608,0,0,12.6062874251497,74.53411382750575,HLA-A;JAK2;HLA-E
1896,GO_Biological_Process_2023,Positive Regulation Of Regulatory T Cell Differentiation (GO:0045591),3 of 17,0.0027055351951788,0.0378324456341608,0,0,12.6062874251497,74.53411382750575,SOCS1;BCL6;HLA-DRA
1897,GO_Biological_Process_2023,ISG15-protein Conjugation (GO:0032020),2 of 5,0.0027372312086731,0.0378324456341608,0,0,39.124378109452735,230.86545810385067,ISG15;UBE2L6
1898,GO_Biological_Process_2023,Regulation Of Ribonuclease Activity (GO:0060700),2 of 5,0.0027372312086731,0.0378324456341608,0,0,39.124378109452735,230.86545810385067,OAS1;OAS3
1899,GO_Biological_Process_2023,Protection From Natural Killer Cell Mediated Cytotoxicity (GO:0042270),2 of 5,0.0027372312086731,0.0378324456341608,0,0,39.124378109452735,230.86545810385067,HLA-B;HLA-E
1900,GO_Biological_Process_2023,Positive Regulation Of Type II Interferon Production (GO:0032729),5 of 58,0.002909380360902,0.0399266028251457,0,0,5.572289156626506,32.541138664187415,ISG15;BTN3A2;HLA-A;JAK2;TLR3
1901,GO_Biological_Process_2023,Receptor Signaling Pathway Via JAK-STAT (GO:0007259),4 of 36,0.003048502031096,0.0413631157460877,0,0,7.368993993993994,42.689355556273,STAT1;STAT2;STAT3;JAK2
1902,GO_Biological_Process_2023,Positive Regulation Of Protein Binding (GO:0032092),5 of 59,0.0031356959743693,0.0413631157460877,0,0,5.468819723337796,31.52722139913545,DTX3L;RIPK2;SUB1;B2M;TRIM21
1903,GO_Biological_Process_2023,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),11 of 246,0.0031636762447164,0.0413631157460877,0,0,2.7895574990210155,16.05675031485248,CD40;RIPK2;STAT3;TRIM25;TRIM14;EIF2AK2;RBCK1;CFLAR;TRIM38;TRIM21;TRIM22
1904,GO_Biological_Process_2023,Regulation Of Interleukin-6 Production (GO:0032675),7 of 114,0.0032016199079943,0.0413631157460877,0,0,3.8768620787312376,22.26907717047414,IFIH1;AKIRIN2;CD74;STAT3;HLA-B;CD47;TLR3
1905,GO_Biological_Process_2023,Maintenance Of Protein Location In Nucleus (GO:0051457),3 of 18,0.003206443081092,0.0413631157460877,0,0,11.765269461077844,67.56315441072502,SP100;RANGAP1;PML
1906,GO_Biological_Process_2023,Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),3 of 18,0.003206443081092,0.0413631157460877,0,0,11.765269461077844,67.56315441072502,IFITM3;CIITA;LY6E
1907,GO_Biological_Process_2023,Positive Regulation Of Natural Killer Cell Activation (GO:0032816),3 of 18,0.003206443081092,0.0413631157460877,0,0,11.765269461077844,67.56315441072502,HLA-F;JAK2;HLA-E
1908,GO_Biological_Process_2023,Regulation Of RIG-I Signaling Pathway (GO:0039535),3 of 18,0.003206443081092,0.0413631157460877,0,0,11.765269461077844,67.56315441072502,USP15;DHX58;DDX60
1909,GO_Biological_Process_2023,Regulation Of Adaptive Immune Response (GO:0002819),3 of 18,0.003206443081092,0.0413631157460877,0,0,11.765269461077844,67.56315441072502,AKIRIN2;IRF1;IRF7
1910,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),5 of 60,0.0033744289976566,0.0432418550361956,0,0,5.369112814895948,30.558462121662863,CYLD;SP100;TNFSF10;CFLAR;PML
1911,GO_Biological_Process_2023,Negative Regulation Of Type I Interferon Production (GO:0032480),4 of 38,0.0037208223461892,0.0459447653122215,0,0,6.934817170111288,38.79205361717125,CYLD;DHX58;XAF1;RBX1
1912,GO_Biological_Process_2023,Positive Regulation Of Alpha-Beta T Cell Activation (GO:0046635),3 of 19,0.0037605455602886,0.0459447653122215,0,0,11.02937874251497,61.57913073686957,HLA-DRA;HLA-A;HLA-E
1913,GO_Biological_Process_2023,Regulation Of Protein Binding (GO:0043393),7 of 118,0.0038759653595687,0.0459447653122215,0,0,3.736390936390936,20.74803136511034,DTX3L;RIPK2;SUB1;IFIT1;B2M;TRIM21;IFIT2
1914,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),5 of 62,0.0038906513513863,0.0459447653122215,0,0,5.180194462058761,28.745824733691247,CYLD;TNFSF10;FAS;CTSS;PML
1915,GO_Biological_Process_2023,DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,NBN;SAMHD1
1916,GO_Biological_Process_2023,G-quadruplex DNA Unwinding (GO:0044806),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,DHX36;HNRNPA2B1
1917,GO_Biological_Process_2023,RIG-I Signaling Pathway (GO:0039529),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,OAS3;TRIM25
1918,GO_Biological_Process_2023,Regulation Of Histamine Secretion By Mast Cell (GO:1903593),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,VAMP8;SNX6
1919,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I (GO:0042590),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,HLA-A;IFI30
1920,GO_Biological_Process_2023,Regulation Of Natural Killer Cell Cytokine Production (GO:0002727),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,HLA-F;HLA-E
1921,GO_Biological_Process_2023,Autophagosome Membrane Docking (GO:0016240),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,VAMP8;VMP1
1922,GO_Biological_Process_2023,Regulation Of Nuclease Activity (GO:0032069),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,OAS1;OAS3
1923,GO_Biological_Process_2023,Cellular Response To Interleukin-9 (GO:0071355),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,STAT1;STAT3
1924,GO_Biological_Process_2023,Toll-Like Receptor 3 Signaling Pathway (GO:0034138),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,OAS1;UNC93B1
1925,GO_Biological_Process_2023,Interleukin-9-Mediated Signaling Pathway (GO:0038113),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,STAT1;STAT3
1926,GO_Biological_Process_2023,Peptide Transport (GO:0015833),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,TAP2;TAP1
1927,GO_Biological_Process_2023,Positive Regulation Of Natural Killer Cell Cytokine Production (GO:0002729),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,HLA-F;HLA-E
1928,GO_Biological_Process_2023,Positive Regulation Of Striated Muscle Contraction (GO:0045989),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,CHGA;GSTO1
1929,GO_Biological_Process_2023,Regulation Of MDA-5 Signaling Pathway (GO:0039533),2 of 6,0.0040601914004794,0.0459447653122215,0,0,29.34179104477612,161.57131073034932,DHX58;DDX60
1930,GO_Biological_Process_2023,Cellular Response To Tumor Necrosis Factor (GO:0071356),7 of 119,0.0040602350741033,0.0459447653122215,0,0,3.702840909090909,20.38974681280914,EIF5A;CD40;STAT1;JAK2;GBP2;GBP1;GBP3
1931,GO_Biological_Process_2023,T Cell Mediated Immunity (GO:0002456),3 of 20,0.0043694849633352,0.048314019451736,0,0,10.380063402606552,56.39602766613993,BTN3A3;BTN3A2;HLA-A
1932,GO_Biological_Process_2023,Cellular Response To Copper Ion (GO:0071280),3 of 20,0.0043694849633352,0.048314019451736,0,0,10.380063402606552,56.39602766613993,MT2A;MT1X;MT1E
1933,GO_Biological_Process_2023,Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),3 of 20,0.0043694849633352,0.048314019451736,0,0,10.380063402606552,56.39602766613993,IRF1;IRF7;TLR3
1934,GO_Biological_Process_2023,Regulation Of Cardiac Muscle Contraction By Calcium Ion Signaling (GO:0010882),3 of 20,0.0043694849633352,0.048314019451736,0,0,10.380063402606552,56.39602766613993,GSTO1;CALM3;ATP1B1
1935,GO_Biological_Process_2023,Positive Regulation Of Binding (GO:0051099),6 of 91,0.0043957078972181,0.0483278112563473,0,0,4.175155500266572,22.65909785896064,DTX3L;RIPK2;SUB1;PARP9;B2M;TRIM21
1936,GO_Biological_Process_2023,Positive Regulation Of Interleukin-1 Production (GO:0032732),5 of 64,0.0044610457712826,0.0487690597030053,0,0,5.00408413314274,27.08396516097026,GSDMD;RIPK2;STAT3;S100A13;JAK2
1937,GO_Biological_Process_2023,Negative Regulation Of Secretion By Cell (GO:1903531),4 of 40,0.0044871080995636,0.048778394228403,0,0,6.548882215548883,35.40683858261972,CHGA;VAMP8;RSAD2;RHBDF2
1938,GO_Biological_Process_2023,Negative Regulation Of Cellular Process (GO:0048523),18 of 537,0.0046139421602868,0.0498769725148326,0,0,2.0813597405186,11.194952721561334,BTG1;APOBEC3G;CCDC125;EIF2AK2;MIA3;IFI35;PLAAT4;PML;IFIT3;HOPX;VAMP8;BST2;BCL6;MDK;IRF1;TXNIP;JAK2;CHMP5
